rfhg_215995.1

Basic information about the TSS

---

TSS ID: rfhg_215995.1 Species: human Chr: chr19		Start: 54188341 End: 54188380 Strand: -
Source datasets	FANTOM5|EPD
Protocol	CAGE|TSS_database
TSS cluster detected*	2

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	pELS,CTCF-bound (EH38D3074326,EH38E1963990)
Category:	pELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: AK293199:0 GeneID: 79143 HGNC/MGI_ID: HGNC:15505 UniProt_ID: B4DDH8 Nearer transcript ids and distances: ENST00000464098.5:-32 S82470:62 ENST00000449249.5:63 BC002512:-126 EU016381:-128 JF432451:-129 view more...

Gene_name: membrane bound O-acyltransferase domain containing 7 Gene_symbol: MBOAT7 Gene_synonyms: BB1 LPIAT1 LPLAT LPLAT11 hMBOA-7 Gene_source: HGNC:15505

TATA-Box annotation

---

Distance to TSS:	1220
Nearest PromoterID:	NM_024298
Entrez ID:	79143
Nearest Unigene:	Hs.467279
Nearest Refseq:	NM_024298
Nearest Ensembl:	ENSG00000125505
Gene Name:	membrane bound O-acyltransferase domain containing 7
Gene Alias:	BB1|LENG4|LPIAT|LPLAT|LRC4|MBOA7|MRT57|OACT7|hMBOA-7
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.625000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@MBOAT7 p2@MBOAT7 p4@MBOAT7 p5@MBOAT7 p6@MBOAT7
Sample		p1@MBOAT7	p2@MBOAT7	p4@MBOAT7	p5@MBOAT7	p6@MBOAT7
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	27.66	3.90	0.39	0.00	0.19
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	28.12	2.63	0.00	0.00	0.81
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	28.16	5.21	0.58	0.00	0.19
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	28.28	3.53	0.62	0.00	0.42
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	24.52	2.70	0.45	0.00	0.22
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	29.46	3.10	0.00	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	32.90	3.92	0.87	0.00	0.44
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	28.82	3.39	0.00	0.00	0.48
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	30.35	5.77	0.85	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	12.75	1.16	0.00	0.58	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	11.32	1.21	0.81	0.00	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	10.98	1.63	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	93.49	19.99	3.87	1.45	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	78.63	18.34	2.86	1.20	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	76.84	19.54	3.29	0.88	1.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	76.20	17.60	1.01	0.50	2.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	79.72	13.98	2.84	1.31	1.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	90.69	15.19	2.11	0.00	2.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	78.91	18.13	1.60	2.13	1.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	82.74	20.31	1.96	0.75	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	80.59	20.32	2.54	1.74	2.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	83.03	21.23	1.38	0.86	1.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	67.86	16.80	0.52	1.68	1.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	67.46	16.74	3.40	1.94	0.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	76.36	18.58	1.03	2.06	1.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	84.19	19.31	1.58	1.27	2.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	93.96	10.44	2.75	1.65	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	99.25	15.32	3.06	1.18	1.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	80.44	19.06	2.10	0.48	1.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	72.75	21.72	2.90	0.90	1.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	64.90	16.33	1.67	1.26	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	71.31	16.61	1.56	1.17	0.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	82.51	18.78	0.84	1.27	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	76.86	19.79	1.65	1.32	1.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	69.00	17.76	2.06	1.12	1.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	66.30	17.25	1.92	0.57	0.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	73.58	16.96	1.23	1.02	1.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	66.09	17.33	2.42	0.60	1.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	65.36	12.69	1.35	1.35	1.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	60.26	15.36	2.16	0.72	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	67.75	18.82	1.65	0.94	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	60.46	12.88	1.76	1.32	1.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	63.48	18.14	2.11	0.63	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	68.53	18.71	2.10	1.22	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	53.81	18.27	1.20	1.81	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	61.19	20.71	2.79	0.70	1.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	68.61	20.15	2.64	1.20	2.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	65.57	19.37	2.09	0.60	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	60.32	21.06	1.68	0.96	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	69.76	19.21	2.63	0.61	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	65.79	15.78	1.64	0.41	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	81.83	26.46	1.56	1.33	1.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	41.98	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	68.13	18.45	2.48	1.42	2.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	61.31	20.88	2.65	0.66	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	31.04	7.55	0.00	0.00	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	45.01	12.86	0.46	0.46	0.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	60.61	24.63	1.30	1.30	2.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	58.45	21.52	1.28	0.64	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	49.35	15.72	0.94	0.63	3.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	61.34	24.68	3.53	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	50.47	19.63	1.12	1.12	2.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	35.83	8.76	0.00	0.00	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	55.72	14.27	1.36	0.00	2.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	55.89	25.67	4.55	0.32	2.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	75.61	29.11	4.26	0.35	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	39.49	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	83.85	34.61	2.93	0.00	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	87.27	36.20	1.98	0.99	1.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	88.19	27.68	3.28	0.47	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	88.76	34.11	2.32	0.00	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	98.68	52.59	4.64	0.00	3.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	81.94	41.89	5.50	0.31	0.92
Adipocyte - breast, donor1	11376-118A8	42.13	7.29	1.11	0.00	0.79
Adipocyte - breast, donor2	11327-117E4	38.66	7.70	1.12	0.00	1.12
Adipocyte - omental, donor1	11473-119C6	52.80	7.76	1.65	0.00	0.89
Adipocyte - omental, donor2	11474-119C7	34.38	5.98	0.75	0.00	0.75
Adipocyte - omental, donor3	11475-119C8	36.51	8.37	0.33	0.00	1.34
Adipocyte - perirenal, donor1	11476-119C9	44.66	14.04	2.55	0.00	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	21.99	1.10	0.00	0.00	2.20
Adipocyte - subcutaneous, donor2	11336-117F4	51.03	8.58	0.00	0.00	2.71
Adipocyte - subcutaneous, donor3	11408-118E4	36.84	2.09	0.35	0.00	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	53.39	4.11	0.78	0.59	0.59
Adipocyte differentiation, day04, donor2	13022-139D7	42.98	3.60	1.03	0.00	0.51
Adipocyte differentiation, day04, donor3	13025-139E1	50.46	6.13	1.12	0.56	1.12
Adipocyte differentiation, day04, donor4	13028-139E4	34.68	3.53	0.00	0.59	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	31.45	2.73	0.32	0.32	0.16
Adipocyte differentiation, day08, donor2	13023-139D8	33.24	4.52	0.00	0.65	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	19.19	2.13	0.53	0.53	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	20.03	1.11	0.00	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	31.61	2.08	0.00	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	31.90	2.01	0.25	0.00	0.50
Adipocyte differentiation, day12, donor3	13027-139E3	21.60	2.95	0.00	0.65	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	21.31	1.52	0.00	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	108.29	22.10	4.20	1.10	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	119.77	25.82	1.43	0.72	1.08
Alveolar Epithelial Cells, donor3	11671-122G6	68.29	7.19	1.20	1.20	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	85.10	12.41	1.08	0.54	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	108.78	8.37	0.00	0.00	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	87.11	19.31	3.70	0.41	0.82
Anulus Pulposus Cell, donor1	11248-116E6	69.80	12.36	1.49	0.00	0.00
Anulus Pulposus Cell, donor2	11463-119B5	58.78	17.39	2.94	0.24	0.98
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	84.47	21.57	0.90	0.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	120.26	29.09	5.64	2.60	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	62.07	27.82	2.14	4.28	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	78.32	23.02	2.69	0.60	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	61.97	26.56	1.26	0.00	2.53
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	89.11	27.06	4.62	1.98	1.98
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	84.15	23.72	1.30	1.62	0.65
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	88.35	24.76	4.37	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	89.08	20.19	1.19	1.78	2.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	77.96	24.10	1.13	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	82.73	37.01	2.90	1.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	87.76	17.55	3.76	2.51	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	101.31	24.71	4.28	1.81	0.49
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	83.25	30.03	1.36	4.09	2.73
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	89.57	25.03	3.02	1.21	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	98.58	24.11	2.68	1.61	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	85.78	26.64	2.83	2.83	0.57
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	94.89	25.39	3.21	2.14	0.53
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	97.55	14.63	2.93	0.98	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	77.95	29.69	2.49	1.33	0.83
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	66.04	33.62	4.80	4.80	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	81.42	28.32	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	89.37	39.62	3.77	2.92	0.34
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	79.70	25.17	4.19	4.19	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	92.23	22.33	0.97	1.46	1.46
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	87.65	30.36	3.42	0.38	1.14
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	95.70	18.17	1.21	3.63	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	79.80	26.22	3.42	1.14	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	87.65	27.36	4.49	2.14	0.64
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	85.43	26.58	3.10	1.55	1.03
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	94.31	25.34	1.41	0.47	0.94
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	93.25	31.19	3.54	3.22	0.64
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	77.77	17.12	4.28	0.71	2.85
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	77.21	27.49	5.26	1.75	1.17
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	81.89	24.99	3.01	1.51	0.60
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	109.30	30.89	2.38	3.56	2.38
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	103.75	25.94	1.02	3.56	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	87.36	29.54	6.88	2.04	1.27
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	63.54	19.70	2.54	0.64	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	86.74	30.64	2.59	0.00	1.73
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	74.09	28.58	2.75	1.48	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	84.67	22.62	2.90	1.74	0.58
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	95.42	28.34	2.83	0.94	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	85.10	24.75	4.07	1.53	0.85
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	106.55	18.53	6.95	2.32	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	88.73	38.03	2.11	2.11	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	82.98	32.16	4.93	1.50	0.86
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	105.89	31.89	3.01	1.80	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	83.83	23.33	2.19	1.46	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	83.68	27.82	3.68	2.07	0.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	76.51	15.30	7.65	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	81.61	22.12	3.05	1.27	0.51
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	83.81	33.65	5.57	1.03	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	93.02	29.68	2.14	2.75	1.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	91.78	26.29	5.26	1.91	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	84.26	32.37	4.43	2.88	0.67
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	68.66	24.41	0.00	1.53	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	93.61	26.03	1.66	1.66	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	68.05	28.33	3.71	1.85	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	73.78	27.62	3.63	0.73	0.73
Astrocyte - cerebellum, donor1	11500-119F6	74.30	15.60	2.46	0.25	0.37
Astrocyte - cerebellum, donor2	11580-120F5	77.54	20.03	2.05	0.17	0.00
Astrocyte - cerebellum, donor3	11661-122F5	59.78	5.24	0.84	0.00	0.63
Astrocyte - cerebral cortex, donor1	11235-116D2	55.08	8.02	2.09	0.00	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	60.02	10.03	1.62	0.49	0.49
Astrocyte - cerebral cortex, donor3	11392-118C6	53.70	6.12	1.49	0.00	0.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	20.30	4.13	0.46	0.00	0.23
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	19.54	4.26	0.63	0.00	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	16.27	2.39	0.46	0.00	0.34
Basophils, donor1	12241-129G9	83.69	8.89	1.05	1.31	0.52
Basophils, donor2	12242-129H1	43.66	2.53	0.36	0.36	0.00
Basophils, donor3	12243-129H2	56.45	3.82	0.88	0.00	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	79.99	8.62	0.43	0.00	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	155.90	30.63	1.37	0.00	2.29
Bronchial Epithelial Cell, donor3	11672-122G7	71.74	21.52	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	54.61	11.30	0.00	0.00	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	71.33	12.06	1.04	0.00	0.42
Bronchial Epithelial Cell, donor6	11461-119B3	42.14	5.76	0.46	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	52.90	7.92	0.54	0.00	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	16.39	1.13	0.00	0.00	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	37.50	3.26	0.23	0.00	0.47
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	142.30	14.39	3.84	2.56	0.64
CD133+ stem cells - cord blood derived, pool1	12223-129E9	206.84	10.34	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	86.79	3.38	0.00	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	63.85	4.64	1.11	0.37	0.19
CD14+ Monocytes, donor3	11381-118B4	74.42	5.71	1.32	0.22	0.44
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	46.70	1.13	0.00	0.00	0.57
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	36.77	1.90	0.00	0.00	0.76
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	46.02	0.66	0.66	0.00	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	162.47	10.41	0.58	2.31	3.04
CD14+ monocytes - mock treated, donor2	11873-125C1	65.78	6.34	0.60	1.21	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	92.63	7.58	0.71	0.71	1.18
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	107.47	6.19	1.34	1.84	0.84
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	55.75	2.76	0.00	0.83	0.83
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	61.73	3.22	0.50	2.48	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	147.63	7.44	1.17	1.37	1.17
CD14+ monocytes - treated with BCG, donor2	11870-125B7	87.96	6.77	0.89	1.60	0.53
CD14+ monocytes - treated with BCG, donor3	11880-125C8	96.41	5.22	1.09	2.83	0.65
CD14+ monocytes - treated with Candida, donor1	11868-125B5	113.79	3.51	0.47	1.40	1.17
CD14+ monocytes - treated with Candida, donor2	11878-125C6	50.16	3.17	0.53	1.06	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	53.25	5.55	2.22	2.22	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	129.56	7.14	2.38	2.23	1.64
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	58.47	3.79	0.60	1.00	0.80
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	51.63	2.71	0.83	1.46	0.42
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	129.95	6.41	0.69	2.06	1.83
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	62.43	2.94	0.68	0.68	1.13
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	60.23	4.36	0.44	1.75	0.87
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	174.31	12.10	0.81	4.57	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	118.63	8.90	1.05	1.74	1.22
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	128.35	7.15	0.84	1.68	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	116.47	5.14	0.73	0.18	0.37
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	53.19	5.64	1.06	0.35	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	51.33	1.75	0.88	0.88	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	155.54	8.37	1.22	4.01	0.70
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	83.63	6.32	1.12	2.60	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	121.57	6.90	0.43	2.80	0.43
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	112.61	5.32	0.82	0.82	0.82
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	65.14	2.78	0.23	0.46	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	62.17	2.32	0.70	0.23	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	54.71	5.67	0.44	0.22	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	72.99	5.77	0.23	0.00	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	58.27	4.98	0.65	0.00	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	168.18	13.08	0.78	0.62	0.47
CD14+CD16- Monocytes, donor2	11799-124C8	135.87	11.00	0.87	0.35	0.35
CD14+CD16- Monocytes, donor3	11910-125G2	128.88	10.70	1.78	0.45	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	47.21	2.55	0.26	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	43.03	2.20	0.44	0.00	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	38.53	4.21	0.42	0.00	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	4.06	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	18.98	2.03	0.00	0.68	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	16.57	1.04	1.04	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	25.59	3.20	0.00	0.00	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	11.26	0.54	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	11.23	1.40	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	19.61	1.57	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	11.86	1.32	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	10.68	0.82	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	7.98	0.73	0.00	0.00	0.73
CD19+ B Cells, donor3	11705-123B4	4.54	1.51	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	9.70	1.21	0.00	0.00	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	13.18	3.99	0.80	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	86.35	12.05	0.00	7.03	0.00
CD34+ Progenitors, donor2	11625-122B5	67.98	6.74	0.56	1.69	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	74.02	12.78	3.38	0.38	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	72.61	11.05	1.35	0.90	0.45
CD4+ T Cells, donor1	11225-116C1	12.50	2.50	0.00	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	7.35	0.61	0.61	0.00	0.61
CD4+ T Cells, donor3	11382-118B5	14.03	1.22	0.30	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	25.01	6.38	0.51	0.00	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	25.83	7.41	0.00	0.00	0.67
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	23.28	7.19	0.29	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	11.38	0.47	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	14.75	0.70	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	13.18	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	33.96	11.71	1.59	1.01	0.29
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	32.37	11.02	1.36	0.34	0.34
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	32.89	11.61	2.58	1.29	0.16
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	16.14	2.69	0.00	0.00	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	12.93	1.05	0.35	0.00	0.70
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	16.72	2.20	0.44	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	49.33	14.34	1.69	0.84	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	46.33	19.32	1.66	0.21	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	45.44	24.06	2.00	0.33	0.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	11.42	0.82	0.27	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	11.25	0.54	0.54	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	14.35	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	39.68	11.13	1.48	0.19	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	34.01	10.61	1.30	0.43	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	25.22	7.15	0.84	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	9.10	1.52	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	16.03	1.73	0.43	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	11.77	2.61	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	15.84	2.97	0.49	0.00	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	14.77	2.77	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	15.35	1.40	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	31.02	2.77	0.55	0.00	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	19.14	3.44	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	26.18	1.54	1.54	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	53.72	3.58	0.72	0.00	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	34.62	4.15	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	8.84	1.31	0.00	0.00	0.33
CD8+ T Cells, donor2	11307-117C2	10.14	1.13	0.75	0.38	0.00
CD8+ T Cells, donor3	11383-118B6	7.83	0.25	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	20.42	7.34	0.92	0.23	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	19.41	8.39	0.72	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	25.17	6.29	0.55	0.27	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	20.11	6.90	0.30	0.30	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	21.84	9.12	0.96	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	17.96	6.14	1.14	0.00	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	23.25	6.52	0.87	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	26.06	7.90	0.53	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	33.07	9.85	1.64	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	35.62	7.85	0.30	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	33.70	9.30	0.87	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	21.58	9.06	2.66	0.27	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	30.20	7.88	0.44	0.44	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	27.33	8.65	0.91	0.91	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	29.09	10.44	0.00	1.49	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	19.81	5.04	0.72	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	23.88	6.91	0.29	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	20.03	5.42	0.71	0.24	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	27.57	10.46	2.22	0.32	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	28.30	9.23	0.31	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	25.01	8.01	1.60	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	19.12	4.97	0.76	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	19.71	7.09	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	21.94	4.54	0.76	0.00	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	16.86	8.83	1.61	0.80	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	18.19	4.90	0.70	0.00	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	23.04	9.02	2.00	1.00	0.00
Cardiac Myocyte, donor1	11525-119I4	29.24	7.31	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	95.85	14.33	0.99	0.49	0.00
Cardiac Myocyte, donor3	11686-122I3	51.77	5.47	0.95	0.00	0.32
Chondrocyte - de diff, donor1	11261-116G1	38.13	9.71	2.77	0.00	0.35
Chondrocyte - de diff, donor2	11338-117F6	33.41	3.91	2.49	0.00	0.71
Chondrocyte - de diff, donor3	11410-118E6	40.62	10.92	1.02	0.11	0.80
Chondrocyte - re diff, donor2	11339-117F7	29.54	8.06	0.00	0.00	2.69
Chondrocyte - re diff, donor3	11411-118E7	27.10	4.45	1.62	0.00	0.81
Ciliary Epithelial Cells, donor1	11242-116D9	58.30	6.66	1.61	0.11	0.23
Ciliary Epithelial Cells, donor2	11323-117D9	61.99	6.20	0.21	0.64	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	62.57	8.05	1.33	0.00	0.09
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	139.84	8.89	2.11	0.55	1.19
Corneal Epithelial Cells, donor1	11526-119I5	76.85	14.49	1.32	0.00	0.22
Corneal Epithelial Cells, donor2	11606-120I4	76.22	3.41	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	58.28	6.39	1.28	0.00	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	35.83	5.12	0.83	0.17	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	34.06	4.10	0.00	0.00	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	13.80	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	36.28	5.08	1.51	0.43	0.43
Dendritic Cells - plasmacytoid, donor1	11228-116C4	47.83	2.39	0.34	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	29.38	0.00	1.31	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	39.68	2.42	0.48	0.00	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	76.38	12.01	2.00	3.17	0.50
Endothelial Cells - Aortic, donor1	11263-116G3	68.65	16.43	2.35	1.17	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	137.16	26.58	4.52	3.96	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	82.96	12.58	0.79	1.97	0.79
Endothelial Cells - Artery, donor1	11264-116G4	95.41	21.82	3.78	2.04	1.75
Endothelial Cells - Artery, donor2	11341-117F9	115.05	20.47	1.88	1.18	0.24
Endothelial Cells - Artery, donor3	11413-118E9	91.16	20.69	2.80	2.10	0.53
Endothelial Cells - Lymphatic, donor1	11236-116D3	116.59	18.40	0.44	5.10	0.66
Endothelial Cells - Lymphatic, donor2	11317-117D3	121.40	23.12	3.35	5.17	0.91
Endothelial Cells - Lymphatic, donor3	11393-118C7	97.82	25.37	1.41	3.38	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	57.64	17.23	0.30	1.49	1.78
Endothelial Cells - Microvascular, donor2	11342-117G1	39.57	6.25	1.56	1.04	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	32.33	7.37	1.28	0.28	0.43
Endothelial Cells - Thoracic, donor1	11266-116G6	112.03	33.61	1.20	5.60	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	120.02	27.25	1.57	4.19	2.10
Endothelial Cells - Umbilical vein, donor1	11243-116E1	144.00	25.59	2.36	2.48	0.99
Endothelial Cells - Umbilical vein, donor2	11324-117E1	91.47	21.73	1.74	1.30	0.43
Endothelial Cells - Umbilical vein, donor3	11400-118D5	91.96	19.54	1.95	2.69	0.12
Endothelial Cells - Vein, donor1	11267-116G7	104.65	7.96	6.83	4.55	0.00
Endothelial Cells - Vein, donor2	11344-117G3	159.26	18.16	1.40	4.19	0.00
Endothelial Cells - Vein, donor3	11416-118F3	92.63	17.43	1.88	1.88	0.94
Eosinophils, donor1	12244-129H3	76.23	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	1257.50	49.51	3.30	18.15	4.95
Eosinophils, donor3	12246-129H5	1362.53	35.67	3.57	14.27	3.57
Esophageal Epithelial Cells, donor1	11507-119G4	64.50	10.26	0.73	0.00	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	68.65	10.40	2.08	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	65.08	0.00	16.27	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	44.34	11.08	0.82	0.41	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	64.93	18.18	1.97	0.66	2.74
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	17.77	1.52	0.33	0.22	0.33
Fibroblast - Aortic Adventitial, donor1	11245-116E3	80.65	13.34	1.58	0.49	1.21
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	108.90	36.30	4.50	1.09	0.68
Fibroblast - Aortic Adventitial, donor2	11326-117E3	62.33	14.98	3.06	0.00	1.48
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	125.95	50.59	2.11	1.05	3.43
Fibroblast - Aortic Adventitial, donor3	11401-118D6	70.76	19.93	1.66	1.33	2.33
Fibroblast - Cardiac, donor1	11268-116G8	50.35	12.25	1.81	0.00	0.45
Fibroblast - Cardiac, donor2	11345-117G4	76.55	15.92	1.52	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	76.18	16.88	2.84	0.95	1.10
Fibroblast - Cardiac, donor4	11452-119A3	66.38	11.21	1.52	0.00	1.52
Fibroblast - Cardiac, donor5	11456-119A7	54.82	11.04	1.27	0.13	0.51
Fibroblast - Cardiac, donor6	11460-119B2	48.51	14.70	1.82	0.30	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	55.61	12.46	1.21	0.13	0.27
Fibroblast - Choroid Plexus, donor2	11572-120E6	32.36	6.47	0.86	0.00	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	71.77	11.72	1.46	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	56.97	10.84	1.61	0.00	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	75.98	10.52	1.70	0.17	0.34
Fibroblast - Dermal, donor1	11269-116G9	44.37	17.14	3.76	0.00	1.64
Fibroblast - Dermal, donor2	11346-117G5	52.36	10.38	1.42	1.42	0.47
Fibroblast - Dermal, donor3	11418-118F5	44.24	13.18	2.18	0.48	0.24
Fibroblast - Dermal, donor4	11450-119A1	30.30	8.37	1.24	0.23	0.11
Fibroblast - Dermal, donor5	11454-119A5	31.40	7.15	0.35	0.00	0.17
Fibroblast - Dermal, donor6	11458-119A9	40.61	7.80	1.30	0.32	0.00
Fibroblast - Gingival, donor1	11237-116D4	43.73	8.75	0.62	0.21	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	51.61	13.89	0.79	1.05	1.83
Fibroblast - Gingival, donor2	11318-117D4	48.50	9.49	1.19	0.40	0.13
Fibroblast - Gingival, donor3	11394-118C8	37.13	7.25	1.26	0.29	0.39
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	54.02	8.31	3.12	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	40.53	5.99	0.70	0.18	0.53
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	57.99	14.03	1.25	0.62	0.47
Fibroblast - Gingival, donor6 (control)	11922-125H5	48.55	12.04	1.35	0.81	0.81
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	110.10	36.35	4.23	0.71	0.71
Fibroblast - Gingival, donor7 (control)	11924-125H7	42.26	13.31	2.05	0.44	0.29
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	39.41	9.82	1.50	0.14	0.14
Fibroblast - Gingival, donor8 (control)	11926-125H9	45.52	10.86	1.32	0.22	0.33
Fibroblast - Gingival, donor9 (control)	11927-125I1	40.65	6.60	1.61	0.00	0.73
Fibroblast - Lung, donor1	11270-116H1	63.89	23.11	2.72	1.36	0.00
Fibroblast - Lung, donor2	11347-117G6	46.26	10.45	2.98	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	70.27	13.51	3.17	0.21	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	152.44	64.98	6.66	2.50	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	62.94	37.76	0.00	1.40	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	102.15	36.38	2.80	0.84	0.56
Fibroblast - Mammary, donor1	11540-120B1	81.19	15.83	2.03	0.00	0.41
Fibroblast - Mammary, donor2	11620-122A9	47.93	23.97	0.00	0.00	3.99
Fibroblast - Mammary, donor3	11701-123A9	47.65	5.96	5.96	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	38.21	6.60	0.97	0.39	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	46.87	8.95	0.76	0.00	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	52.63	13.46	2.45	0.00	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	35.87	7.25	1.53	0.00	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	35.91	9.18	1.62	0.27	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	39.78	6.84	1.39	0.23	0.35
Fibroblast - Pulmonary Artery, donor1	11250-116E8	60.13	8.29	1.33	0.33	0.11
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	222.29	58.11	8.74	5.28	0.61
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	56.80	13.36	1.34	0.67	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	42.30	13.84	1.19	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	114.90	43.46	1.79	0.00	0.60
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	44.76	10.30	1.42	0.00	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	51.24	13.20	2.17	0.20	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	222.63	96.57	4.81	2.71	1.20
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	61.42	20.83	2.16	0.86	0.76
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	57.45	23.79	0.25	0.00	0.00
Fibroblast - skin normal, donor1	11553-120C5	63.66	15.26	1.80	0.00	0.82
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	193.89	65.57	6.62	0.80	0.00
Fibroblast - skin normal, donor2	11561-120D4	63.99	20.59	2.81	0.60	0.20
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	81.00	35.66	1.51	0.00	1.21
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	47.55	9.61	1.24	0.00	0.25
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	45.30	13.68	1.88	0.00	0.85
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	198.37	82.76	6.90	1.31	0.66
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	76.70	22.26	2.45	0.75	0.53
Fibroblast - skin walker warburg, donor1	11554-120C6	94.12	24.63	2.53	0.84	0.34
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	42.65	6.27	0.31	0.00	1.41
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	50.55	2.61	1.74	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	59.81	8.67	1.91	0.17	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	61.68	9.63	1.30	0.52	0.78
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	67.46	13.80	1.53	0.00	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	80.38	3.83	0.77	0.00	3.06
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	72.10	1.28	0.64	0.00	2.55
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	84.72	1.14	0.00	0.00	0.86
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	97.62	4.14	0.83	0.00	3.58
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	67.81	6.62	2.28	0.00	2.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	85.59	3.57	0.59	0.00	1.78
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	89.61	5.29	1.06	0.00	8.19
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	59.68	5.87	1.96	0.00	2.61
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	89.77	3.10	0.44	0.00	2.21
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	73.63	3.11	0.71	0.00	1.27
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	62.56	4.80	0.62	0.12	1.48
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	57.49	4.03	0.27	0.00	1.34
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	82.14	7.06	0.87	0.37	0.99
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	67.83	3.18	0.14	0.42	0.69
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	62.41	3.86	1.22	0.20	0.81
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	93.55	8.90	0.91	0.91	1.60
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	99.03	8.97	0.62	0.62	1.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	102.08	7.21	0.44	1.09	1.53
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	88.94	8.27	0.00	0.30	0.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	80.59	3.81	0.95	1.11	1.11
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	102.10	8.27	0.45	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	62.71	3.43	0.40	0.00	1.21
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	57.34	3.22	1.02	0.00	0.51
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	116.87	8.87	1.06	0.89	1.77
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	100.93	8.43	1.25	0.00	1.87
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	85.56	6.66	1.02	0.00	1.54
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	49.57	3.43	0.22	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	92.26	5.16	0.92	0.58	1.08
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	82.69	6.53	1.23	0.82	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	56.12	3.92	1.03	0.21	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	57.53	3.23	0.69	0.12	0.69
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	61.87	7.17	1.33	0.17	1.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	55.11	4.41	0.00	0.00	1.32
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	47.72	3.44	0.25	0.12	1.11
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	62.57	6.32	0.16	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	43.94	4.17	0.64	0.00	2.57
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	46.05	3.70	0.28	0.09	0.76
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	46.03	5.38	0.63	0.00	0.95
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	45.00	4.87	0.91	0.61	0.91
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	37.84	3.14	0.63	0.00	0.42
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	57.96	7.68	0.88	0.00	0.88
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	39.84	4.49	0.28	0.00	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	37.03	5.18	0.65	0.00	0.46
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	45.19	8.56	1.60	0.00	0.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	48.35	7.80	1.22	0.00	0.61
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	38.08	7.38	0.39	0.13	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	44.46	10.03	1.63	0.00	0.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	51.07	7.56	0.74	0.00	0.74
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	49.78	8.33	0.66	0.00	1.10
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	77.36	10.91	0.00	0.00	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	49.73	8.84	1.19	0.00	0.26
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	53.47	10.89	0.81	0.00	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	123.78	16.27	2.80	0.25	1.27
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	59.32	2.99	0.20	0.00	0.80
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	62.55	2.62	0.46	0.00	0.31
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	68.33	2.45	0.41	0.00	0.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	96.38	3.13	0.31	0.00	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	91.27	2.54	0.85	0.00	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	65.95	3.69	0.00	0.00	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	106.42	2.47	2.47	0.00	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	85.48	2.71	0.39	0.00	2.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	99.48	4.81	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	109.55	1.74	0.00	0.00	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	81.04	2.28	0.65	0.00	1.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	65.06	4.12	0.00	0.00	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	109.96	6.66	3.33	0.00	10.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	80.82	3.36	1.12	0.00	1.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	86.61	4.58	0.65	0.00	2.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	104.02	2.52	1.68	0.84	1.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	89.70	2.86	0.32	0.00	1.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	89.67	3.74	0.34	0.00	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	77.26	4.18	0.00	0.00	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	96.79	1.15	0.00	0.00	2.86
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	84.06	2.66	0.30	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	62.68	0.00	0.00	0.00	6.78
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	72.90	3.31	0.41	0.00	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	71.57	2.99	0.23	0.00	1.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	79.03	0.00	5.27	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	63.43	3.08	1.54	0.00	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	57.04	2.61	0.33	0.00	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	46.15	2.68	0.67	0.00	1.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	71.66	2.31	0.39	0.00	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	82.85	3.42	0.34	0.00	1.37
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	84.48	2.48	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	58.51	1.42	0.94	0.00	1.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	58.54	1.21	0.00	0.00	1.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	72.23	1.02	0.00	0.00	2.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	77.37	3.99	0.40	0.00	0.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	56.74	1.48	0.00	0.49	1.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	72.01	1.18	0.00	1.18	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	70.01	2.33	0.00	0.00	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	72.42	2.63	0.00	0.00	1.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	56.80	2.54	0.85	0.00	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	42.38	4.18	0.60	0.00	1.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	45.61	2.43	0.49	0.00	1.94
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	42.23	12.55	2.28	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	57.80	13.72	0.83	0.00	1.25
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	67.47	14.62	1.12	0.00	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	32.35	6.34	1.27	0.00	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	37.60	14.62	1.67	0.00	0.84
Hep-2 cells mock treated, biol_rep1	11898-125E8	74.50	10.44	1.16	0.23	0.35
Hep-2 cells mock treated, biol_rep2	11899-125E9	66.34	10.97	0.84	0.00	0.34
Hep-2 cells mock treated, biol_rep3	11900-125F1	64.16	8.19	0.68	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	70.39	8.53	1.42	0.33	0.22
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	70.71	9.46	1.29	0.43	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	67.38	10.33	0.43	0.22	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	71.98	9.09	1.25	0.37	0.37
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	62.10	7.21	0.86	0.00	0.34
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	67.28	7.37	1.92	0.32	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	81.70	26.30	2.24	0.00	2.24
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	112.53	19.04	1.73	1.30	0.87
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	113.68	18.51	2.64	2.64	2.64
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	74.07	10.23	0.35	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	61.03	10.90	2.91	0.00	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	60.49	7.34	0.52	0.00	0.17
Hepatocyte, donor1	11523-119I2	30.27	1.21	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	52.79	0.00	0.00	0.00	2.15
Hepatocyte, donor3	11684-122I1	39.88	2.45	0.00	0.61	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	20.23	3.92	1.31	0.65	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	80.92	2.10	0.52	0.00	0.87
Iris Pigment Epithelial Cells, donor1	11530-119I9	111.96	18.93	2.33	1.10	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	152.83	41.39	6.37	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	120.16	13.35	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	135.42	54.17	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	110.75	26.30	1.38	0.00	1.38
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	100.11	32.53	12.51	2.50	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	189.89	11.87	11.87	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	125.58	48.70	5.13	0.00	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	77.70	22.85	0.00	4.57	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	149.44	32.49	6.50	4.87	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	93.37	33.35	3.33	1.67	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	72.61	25.41	0.00	0.00	3.63
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	146.91	25.15	1.32	3.97	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	107.54	29.93	1.11	0.00	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	110.00	41.91	0.00	5.24	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	100.15	12.60	3.15	2.52	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	123.73	26.29	4.64	1.55	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	73.17	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	129.21	30.36	2.58	1.29	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	181.92	35.42	1.61	1.61	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	83.64	11.95	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	140.16	34.22	4.07	2.44	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	160.37	32.75	3.78	3.36	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	86.23	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	130.20	34.56	2.41	0.80	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	93.25	25.85	1.85	2.77	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	75.40	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	85.44	13.22	2.83	0.47	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	92.51	27.21	2.72	2.72	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	117.94	29.48	14.74	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	160.34	22.60	5.38	2.15	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	156.27	27.95	5.08	1.27	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	115.01	16.43	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	141.56	31.25	2.55	0.64	1.91
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	156.75	30.99	3.65	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	94.83	63.22	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	139.96	30.70	2.86	0.71	2.14
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	149.32	23.23	0.00	3.32	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	125.09	62.55	20.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	113.59	28.09	2.47	2.47	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	156.29	38.63	5.27	1.76	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	125.73	31.43	3.14	3.14	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	170.37	30.60	4.87	2.09	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	161.56	48.69	2.21	2.21	2.21
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	158.86	35.66	3.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	108.12	26.16	1.74	0.00	2.62
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	80.99	38.25	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	121.96	45.30	0.00	0.00	3.48
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	88.54	27.74	1.07	1.07	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	133.00	20.78	2.77	2.77	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	142.48	22.80	2.85	2.85	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	139.90	24.85	2.76	0.92	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	72.61	18.15	9.08	6.05	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	180.05	37.25	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	102.57	20.09	5.29	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	126.48	14.85	1.55	0.00	0.73
Keratinocyte - epidermal, donor2	11349-117G8	53.88	9.37	1.17	0.00	0.59
Keratinocyte - epidermal, donor3	11421-118F8	66.35	9.28	0.76	0.00	0.28
Keratinocyte - oral, donor1	11251-116E9	67.20	6.36	0.57	0.00	0.00
Keratocytes, donor1	11527-119I6	61.89	12.72	1.38	0.34	0.69
Keratocytes, donor2	11607-120I5	56.25	9.37	3.52	0.00	0.00
Keratocytes, donor3	11688-122I5	45.05	4.15	0.20	0.40	0.40
Krukenberg tumor cell line:HSKTC	10687-109F3	35.17	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	77.67	9.71	2.16	3.24	0.00
Lens Epithelial Cells, donor2	11609-120I7	76.12	9.69	1.96	0.00	0.12
Lens Epithelial Cells, donor3	11690-122I7	86.48	19.07	2.83	0.40	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	42.21	7.71	1.30	0.59	0.36
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	34.33	6.42	0.56	0.00	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	38.88	4.88	0.63	0.16	0.31
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	41.40	7.53	1.61	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	41.29	7.25	0.95	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	28.79	4.74	1.19	0.65	0.22
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	30.78	4.92	0.41	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	36.66	6.07	1.26	0.51	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	32.09	4.50	0.28	0.42	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	33.22	4.35	1.19	0.00	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	39.16	5.04	0.78	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	33.51	6.11	0.93	0.37	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	39.02	4.18	0.70	0.35	0.70
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	44.13	6.92	0.72	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	34.61	6.46	0.96	0.14	0.55
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	25.56	4.62	1.54	0.62	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	31.49	3.74	1.56	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	35.87	5.12	0.55	0.18	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	32.25	6.91	0.33	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	43.35	6.44	1.17	0.00	0.88
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	43.06	3.73	1.00	0.25	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	35.40	4.85	0.97	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	34.74	6.46	1.62	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	36.03	5.30	0.61	0.00	0.30
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	23.33	8.81	0.52	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	42.51	5.86	0.84	0.21	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	36.84	6.47	1.20	0.00	0.45
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	35.77	10.32	1.38	0.00	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	34.62	5.08	1.51	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	31.38	3.82	0.64	0.11	0.53
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	31.98	4.36	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	35.06	2.65	0.99	0.00	0.99
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	35.56	4.09	0.87	0.00	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	40.72	4.81	2.22	0.37	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	31.87	4.69	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	31.90	6.87	0.69	0.27	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	36.35	3.54	0.96	0.96	0.96
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	35.61	6.70	0.30	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	37.23	5.74	1.26	0.14	0.28
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	29.16	8.89	0.36	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	36.84	7.27	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	43.88	4.98	1.40	0.16	0.62
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	41.54	5.37	0.36	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	48.02	5.55	0.98	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	41.20	6.12	0.24	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	39.48	6.31	1.24	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	35.09	5.89	0.51	0.00	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	31.33	5.07	0.60	0.30	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	86.11	4.53	0.00	0.00	2.27
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	107.40	13.04	2.30	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	98.72	14.10	0.00	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	103.67	13.96	2.12	0.00	0.85
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	94.95	14.77	2.81	0.70	1.41
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	113.94	19.61	0.93	1.87	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	89.14	11.34	3.09	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	101.10	17.84	1.19	2.38	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	103.60	14.48	2.71	0.23	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	81.14	11.63	2.04	0.00	0.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	80.58	13.51	0.45	0.00	1.35
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	153.51	16.66	2.71	0.27	0.95
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	109.38	9.24	0.51	2.05	1.54
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	88.92	8.47	1.06	0.35	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	92.62	17.32	1.33	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	90.67	11.21	2.04	0.00	1.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	91.78	14.67	2.40	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	87.10	13.04	1.32	0.38	1.13
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	117.19	13.50	1.84	0.61	2.45
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	111.71	16.31	0.82	0.82	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	92.04	9.37	0.83	0.00	2.08
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	87.72	12.05	1.96	0.56	1.68
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	111.28	16.49	0.00	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	95.80	10.16	2.03	0.00	0.87
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	88.18	10.46	1.49	0.30	1.49
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	93.50	11.07	0.00	0.00	1.66
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	113.12	16.61	1.41	0.35	1.41
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	91.46	12.17	0.37	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	85.19	10.36	4.61	0.00	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	122.42	17.65	3.07	0.38	1.15
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	119.45	8.49	1.13	0.57	1.13
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	103.38	17.23	3.28	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	132.40	13.10	1.81	0.00	0.90
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	107.72	15.08	1.44	0.72	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	123.24	20.17	3.73	0.75	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	118.54	12.26	2.23	0.37	1.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	92.18	12.92	0.86	0.43	1.29
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	99.33	19.69	0.86	0.00	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	109.62	19.66	0.67	0.67	2.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	101.36	10.26	0.60	0.60	1.81
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	91.72	11.38	1.42	0.71	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	107.24	18.56	2.41	0.00	1.37
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	103.06	16.10	2.15	0.54	2.68
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	112.45	16.16	0.00	0.00	2.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	120.01	17.41	1.85	0.00	1.85
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	104.66	9.30	2.33	1.16	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	112.12	13.75	1.06	0.00	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	120.05	19.21	2.80	0.00	2.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	85.77	12.36	3.63	0.00	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	96.58	12.26	0.77	0.00	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	107.53	15.29	2.47	0.49	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	95.03	9.41	1.88	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	113.64	12.57	1.51	0.50	1.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	114.46	15.77	2.70	0.00	0.90
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	108.43	13.77	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	107.33	21.82	3.56	0.00	0.89
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	108.31	15.25	3.13	0.39	1.56
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	84.45	7.26	2.64	1.32	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	111.05	9.34	3.63	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	115.08	13.13	1.31	0.44	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	107.91	11.18	1.68	1.12	2.24
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	111.74	15.90	1.32	0.88	2.21
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	109.54	13.50	2.31	0.00	2.31
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	82.03	13.17	3.54	0.00	2.03
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	102.37	13.94	3.84	0.00	0.96
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	107.34	14.71	1.19	0.40	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	89.32	13.37	1.82	0.00	1.22
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	94.07	13.83	2.08	0.00	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	114.76	13.30	1.52	0.38	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	95.54	14.98	2.07	0.52	2.07
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	122.74	19.95	1.81	0.00	1.21
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	112.50	14.89	1.58	0.32	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	110.35	14.39	1.60	0.00	3.20
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	121.83	17.24	1.72	0.00	1.72
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	125.99	15.43	2.57	1.03	2.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	136.52	14.15	1.41	0.00	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	127.68	18.16	2.27	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	125.64	13.73	1.66	0.42	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	130.77	12.53	2.35	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	118.58	15.45	1.67	0.00	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	138.93	11.15	2.79	0.46	0.93
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	111.06	10.70	3.35	0.67	2.01
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	134.20	25.66	2.14	0.00	2.14
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	137.39	18.18	2.83	0.00	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	95.45	11.93	0.92	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	126.25	20.45	0.00	0.00	1.78
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	148.74	13.11	0.57	0.57	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	131.91	12.27	0.77	0.00	1.53
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	140.08	25.17	2.74	0.00	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	139.87	15.59	2.67	0.45	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	166.11	13.78	1.30	0.52	0.52
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	149.86	13.93	1.33	0.66	1.33
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	172.52	27.02	2.08	0.00	2.08
Macrophage - monocyte derived, donor1	11232-116C8	42.39	4.10	0.00	0.00	0.23
Macrophage - monocyte derived, donor2	11313-117C8	28.26	6.06	0.55	0.00	0.00
Macrophage - monocyte derived, donor3	11389-118C3	35.52	6.82	1.05	0.00	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	28.14	5.31	1.06	0.00	0.53
Mallassez-derived cells, donor2	11929-125I3	54.82	15.85	1.90	0.00	0.63
Mallassez-derived cells, donor3	11930-125I4	49.06	11.26	0.69	0.00	0.28
Mammary Epithelial Cell, donor1	11273-116H4	64.87	9.86	1.40	0.00	0.40
Mammary Epithelial Cell, donor2	11350-117G9	54.15	9.84	0.58	0.00	0.00
Mammary Epithelial Cell, donor3	11422-118F9	62.61	9.23	1.00	0.00	0.75
Mast cell - stimulated, donor1	11487-119E2	122.71	27.12	7.46	42.71	12.20
Mast cell, donor1	11563-120D6	179.73	68.24	10.81	59.48	5.19
Mast cell, donor2	11565-120D8	262.70	73.10	8.92	26.15	8.62
Mast cell, donor3	11566-120D9	287.71	76.77	10.58	30.39	5.63
Mast cell, donor4	11567-120E1	293.77	76.77	9.57	19.86	8.69
Mast cell, expanded and stimulated, donor5	11940-126A5	148.82	76.85	11.31	68.53	4.77
Mast cell, expanded and stimulated, donor8	11942-126A7	131.91	55.45	8.17	49.03	12.84
Mast cell, expanded, donor5	11939-126A4	213.04	96.83	15.95	71.59	8.60
Mast cell, expanded, donor8	11941-126A6	182.60	86.53	9.87	67.78	15.73
Melanocyte - dark, donor1	11502-119F8	35.62	4.48	0.50	0.00	0.00
Melanocyte - dark, donor2	11582-120F7	103.13	15.23	3.46	1.38	0.35
Melanocyte - dark, donor3	11663-122F7	62.01	6.52	0.94	0.00	0.14
Melanocyte - light, donor1	11274-116H5	48.90	5.88	0.94	0.00	0.71
Melanocyte - light, donor2	11351-117H1	46.41	6.82	2.05	0.68	1.36
Melanocyte - light, donor3	11423-118G1	37.29	6.07	2.60	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	43.32	5.21	0.31	0.00	0.42
Melanocyte, donor2 (MC+2)	12739-135I3	55.40	13.18	1.61	0.00	0.81
Melanocyte, donor3 (MC+3)	12837-137B2	69.64	6.70	1.34	0.00	0.54
Meningeal Cells, donor1	11493-119E8	67.86	12.78	2.11	0.37	0.00
Meningeal Cells, donor2	11573-120E7	69.98	18.05	1.32	0.00	0.44
Meningeal Cells, donor3	11654-122E7	61.78	9.05	1.87	0.33	0.16
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	47.62	7.41	2.28	0.00	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	67.93	13.69	3.62	0.40	0.40
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	183.98	26.28	3.94	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	54.94	13.08	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	34.45	10.05	0.00	0.00	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	92.54	19.69	3.60	0.21	0.85
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	116.61	34.68	3.52	1.01	1.51
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	59.11	13.40	1.54	0.00	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	40.91	8.04	1.46	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	62.40	13.50	2.05	0.41	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	68.42	17.59	2.35	0.28	0.69
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	108.54	13.75	3.35	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	60.52	8.29	1.18	0.26	0.53
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	82.49	10.09	0.59	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	58.39	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	57.64	21.13	1.92	1.92	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	33.32	4.25	0.71	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	50.66	7.19	0.31	0.00	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	53.70	16.69	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	118.80	39.78	6.89	3.45	3.18
Mesothelial Cells, donor2	12156-128G5	89.58	22.02	2.50	2.50	0.50
Mesothelial Cells, donor3	11402-118D7	98.50	37.79	5.49	2.60	1.01
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	75.62	8.10	2.70	1.35	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	35.71	6.90	1.23	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	41.52	6.77	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	58.77	6.91	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	28.52	2.79	0.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	37.55	8.50	1.45	0.00	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	53.27	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	35.79	8.51	1.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	54.00	13.03	2.79	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	39.22	5.89	0.61	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	48.31	8.32	1.19	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	51.31	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	33.63	2.65	1.77	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	50.91	7.22	1.14	0.00	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	23.69	1.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	30.56	3.61	0.64	0.21	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	39.60	4.60	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	28.91	5.66	1.49	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	51.98	3.35	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	22.83	2.76	0.75	0.25	0.50
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	33.04	5.94	0.95	0.24	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	12.72	0.55	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	27.40	3.68	0.69	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	30.29	5.47	2.10	0.21	0.42
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	35.67	4.69	0.20	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	24.03	3.65	0.64	0.00	0.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	38.01	7.78	1.33	0.22	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	30.96	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	23.00	4.16	1.10	0.00	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	30.42	5.07	0.51	0.00	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	31.48	1.66	1.66	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	24.73	4.08	0.82	0.00	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	35.29	5.59	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	39.25	0.00	0.00	0.00	1.09
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	28.83	5.77	1.44	0.00	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	36.42	5.20	0.80	0.40	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	37.02	2.74	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	32.04	5.01	1.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	26.95	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	24.46	6.12	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	30.22	4.82	0.44	0.44	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	24.28	7.73	1.10	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	30.74	2.56	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	33.96	3.47	0.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	26.44	0.70	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	41.99	2.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	52.99	7.18	0.68	0.34	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	31.07	4.38	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	35.15	1.07	0.71	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	40.96	6.17	0.56	0.00	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	29.93	3.33	0.42	0.00	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	34.96	4.08	1.75	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	44.34	6.94	0.90	0.00	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	33.39	9.60	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	64.97	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	36.94	5.54	0.92	0.92	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	47.24	6.26	1.71	0.00	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	46.98	6.49	0.41	0.14	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	52.35	12.18	0.26	0.00	0.52
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	53.62	18.02	0.43	0.86	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	50.82	5.72	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	44.30	3.47	0.53	0.27	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	64.06	14.07	1.50	0.90	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	50.71	6.36	0.85	0.00	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	45.23	5.73	0.32	0.64	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	49.75	13.71	1.55	0.00	0.44
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	47.78	6.45	0.76	0.38	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	50.57	8.24	2.56	0.28	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	45.23	11.80	2.21	0.25	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	61.91	5.87	0.65	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	47.04	9.11	1.47	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	66.89	14.70	1.73	0.58	0.58
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	94.79	16.49	2.47	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	47.35	7.44	2.38	0.00	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	45.20	3.77	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	23.17	3.56	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	49.29	4.27	0.66	0.00	0.66
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	36.82	8.42	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	38.35	2.37	0.20	0.00	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	44.70	5.59	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	27.04	2.25	0.38	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	33.83	5.33	1.07	0.00	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	33.14	2.04	0.34	0.00	0.34
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	32.42	4.42	0.74	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	38.84	4.40	0.73	0.37	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	34.22	7.78	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	14.43	1.07	0.53	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	23.18	11.59	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	37.37	8.08	2.02	0.00	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	17.71	2.53	0.00	0.00	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	12.26	1.36	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	8.90	1.91	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	2.43	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	10.57	6.04	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	79.94	22.84	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	13.05	6.52	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	19.01	0.00	0.00	4.75	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	25.10	0.00	0.00	12.55	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	59.46	11.20	1.51	0.00	0.43
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	48.60	3.14	0.52	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	74.76	40.05	4.67	1.33	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	65.11	15.86	3.34	0.42	0.83
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	47.92	11.41	0.76	0.00	0.76
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	79.79	17.55	7.98	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	55.76	21.08	1.36	4.08	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	20.21	5.51	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	59.01	16.74	4.19	0.00	1.67
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	69.73	19.76	3.49	1.16	0.70
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	61.34	17.56	2.43	0.54	1.08
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	49.83	11.77	1.47	0.42	0.42
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	22.27	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	61.55	30.28	3.47	1.99	0.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	40.06	15.16	1.08	0.54	1.08
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	63.70	19.04	3.17	0.68	1.59
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	42.30	9.47	1.31	0.65	0.65
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	48.30	11.48	0.91	0.36	0.91
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	54.63	21.75	3.18	0.53	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	48.62	16.21	4.80	1.80	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	39.38	8.53	0.98	0.00	0.66
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	57.73	21.30	3.58	0.65	0.81
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	61.91	12.70	2.47	0.35	0.71
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	45.01	15.47	2.81	0.00	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	50.57	12.87	0.92	0.46	1.38
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	43.70	15.75	2.25	0.64	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	36.56	12.07	0.69	0.00	1.03
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	30.34	7.59	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	52.80	8.69	2.01	0.22	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	45.30	11.43	1.27	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	36.55	7.60	0.71	0.00	1.42
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	40.78	7.30	3.00	0.43	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	45.14	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	50.65	11.00	2.00	0.00	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	44.64	5.41	0.45	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	30.16	8.33	3.57	0.00	1.19
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	39.00	9.29	1.86	0.93	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	30.65	7.57	0.00	0.00	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	50.19	12.38	2.61	0.00	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	52.29	13.95	3.49	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	28.04	6.78	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	37.04	7.94	2.65	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	41.22	9.31	0.66	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	32.24	13.39	1.49	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	42.49	13.78	1.15	0.00	0.77
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	79.54	14.21	1.21	0.00	1.81
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	41.33	6.85	0.22	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	32.53	6.10	0.68	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	20.44	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	36.58	12.19	1.22	0.00	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	43.75	9.76	0.31	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	58.11	11.20	1.82	0.00	1.51
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	43.51	7.12	0.79	0.00	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	28.34	2.27	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	5.06	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	40.00	7.45	0.99	0.00	0.12
Myoblast, donor2	11322-117D8	61.95	12.08	1.92	0.19	0.19
Myoblast, donor3	11398-118D3	50.11	11.10	2.52	0.17	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	29.62	5.84	0.88	0.00	0.15
Natural Killer Cells, donor1	11230-116C6	14.76	1.85	0.31	0.00	0.62
Natural Killer Cells, donor2	11311-117C6	8.44	0.60	1.21	0.00	0.30
Natural Killer Cells, donor3	11387-118C1	14.72	1.66	0.37	0.00	0.18
Neural stem cells, donor1	11275-116H6	105.62	9.44	2.54	0.36	2.18
Neural stem cells, donor2	11352-117H2	82.80	11.55	0.00	0.00	0.00
Neurons, donor1	11494-119E9	35.27	4.55	1.14	0.00	0.00
Neurons, donor2	11574-120E8	62.53	7.71	0.66	0.00	0.22
Neurons, donor3	11655-122E8	37.00	5.76	0.00	0.00	0.00
Neutrophils, donor1	11233-116C9	1407.78	90.94	4.64	16.70	21.34
Neutrophils, donor2	11314-117C9	953.73	89.87	8.70	20.29	14.49
Neutrophils, donor3	11390-118C4	1823.36	167.98	11.00	14.66	15.27
Nucleus Pulposus Cell, donor1	11252-116F1	78.37	10.33	0.95	0.12	0.47
Nucleus Pulposus Cell, donor2	11409-118E5	90.84	14.00	1.30	0.33	1.30
Nucleus Pulposus Cell, donor3	11462-119B4	45.32	11.23	2.21	0.60	0.20
Olfactory epithelial cells, donor1	11933-125I7	54.65	15.97	2.48	0.55	0.41
Olfactory epithelial cells, donor2	11934-125I8	79.32	24.17	3.18	0.58	1.16
Olfactory epithelial cells, donor3	11935-125I9	57.89	14.07	3.18	0.57	0.11
Olfactory epithelial cells, donor4	11936-126A1	67.30	21.72	2.24	0.10	0.19
Oligodendrocyte - precursors, donor1	11496-119F2	90.87	16.85	1.20	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	33.61	6.81	0.43	0.21	0.43
Osteoblast - differentiated, donor2	11353-117H3	54.87	8.00	3.43	0.00	1.14
Osteoblast - differentiated, donor3	11425-118G3	34.14	9.31	1.86	0.00	0.62
Osteoblast, donor1	11277-116H8	60.78	9.97	1.56	0.20	0.39
Osteoblast, donor2	11354-117H4	71.64	10.53	4.21	0.00	0.00
Osteoblast, donor3	11426-118G4	56.70	12.26	2.31	0.18	0.18
Pancreatic stromal cells, donor1	11249-116E7	66.80	15.67	2.19	1.10	1.01
Pericytes, donor1	11491-119E6	87.23	13.35	1.00	0.00	0.22
Pericytes, donor2	11571-120E5	59.53	11.09	2.72	0.00	1.13
Pericytes, donor3	11652-122E5	93.79	19.33	1.63	0.00	0.20
Perineurial Cells, donor1	11499-119F5	73.35	12.66	2.03	0.00	0.34
Perineurial Cells, donor2	11579-120F4	130.84	19.78	1.75	0.64	0.46
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	87.33	5.74	0.96	0.00	1.27
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	76.89	6.86	1.96	0.49	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	59.92	4.01	0.39	0.00	0.13
Placental Epithelial Cells, donor1	11278-116H9	110.97	11.00	2.63	0.48	0.72
Placental Epithelial Cells, donor2	11355-117H5	94.26	9.98	3.33	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	105.62	12.17	2.55	0.00	1.18
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	54.75	18.35	2.22	0.00	1.58
Preadipocyte - breast, donor1	11467-119B9	52.71	12.94	2.06	0.00	0.94
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	50.12	14.36	2.22	0.00	0.26
Preadipocyte - breast, donor2	11328-117E5	47.06	12.38	2.25	0.00	2.03
Preadipocyte - omental, donor1	11468-119C1	66.60	15.98	1.92	0.00	1.81
Preadipocyte - omental, donor2	11329-117E6	62.85	15.28	1.31	0.00	0.44
Preadipocyte - omental, donor3	11403-118D8	67.61	15.76	2.15	0.14	1.15
Preadipocyte - perirenal, donor1	11469-119C2	56.10	19.69	0.98	0.98	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	93.67	23.34	6.45	0.92	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	73.13	19.48	3.19	0.89	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	78.67	24.01	3.75	1.02	2.38
Preadipocyte - visceral, donor1	11280-116I2	79.73	18.44	2.51	1.02	0.75
Preadipocyte - visceral, donor2	11357-117H7	92.50	24.39	2.76	0.46	1.38
Preadipocyte - visceral, donor3	11429-118G7	53.92	22.67	2.72	0.63	1.36
Prostate Epithelial Cells (polarized), donor1	11253-116F2	81.16	2.11	0.60	0.30	2.87
Prostate Epithelial Cells, donor2	11331-117E8	107.25	23.29	1.90	0.00	2.71
Prostate Epithelial Cells, donor3	11404-118D9	38.40	3.25	0.37	0.12	0.31
Prostate Stromal Cells, donor1	11254-116F3	83.94	11.96	2.85	0.57	0.80
Prostate Stromal Cells, donor2	11332-117E9	119.23	25.82	3.59	1.26	1.08
Prostate Stromal Cells, donor3	11405-118E1	77.48	20.65	4.90	0.73	1.56
Renal Cortical Epithelial Cells, donor1	11516-119H4	122.63	20.44	1.09	0.36	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	91.63	11.44	1.32	0.35	0.35
Renal Epithelial Cells, donor1	11517-119H5	164.85	21.30	2.03	0.51	0.00
Renal Epithelial Cells, donor2	11597-120H4	83.94	11.38	2.13	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	75.38	8.05	1.48	0.00	0.21
Renal Glomerular Endothelial Cells, donor1	11514-119H2	132.77	39.49	2.72	4.09	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	131.93	31.94	3.10	5.26	0.94
Renal Glomerular Endothelial Cells, donor3	11675-122H1	90.14	21.98	1.11	1.55	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	206.95	49.91	3.33	2.66	2.66
Renal Mesangial Cells, donor1	11518-119H6	135.35	24.65	3.08	0.66	0.44
Renal Mesangial Cells, donor2	11598-120H5	80.88	13.79	1.25	0.00	3.13
Renal Mesangial Cells, donor3	11679-122H5	101.26	15.26	2.50	0.83	1.11
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	110.59	13.69	0.81	0.27	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	80.54	15.60	0.84	0.00	0.84
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	74.63	11.19	2.12	0.39	0.58
Retinal Pigment Epithelial Cells, donor0	11215-116A9	89.71	8.82	1.30	0.26	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	138.14	22.46	2.27	0.85	0.85
Retinal Pigment Epithelial Cells, donor2	11608-120I6	139.96	25.73	3.09	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	66.99	4.27	1.00	0.00	1.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	93.55	7.62	0.13	0.94	2.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	40.20	6.25	0.00	0.00	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	40.18	12.66	0.00	0.00	1.10
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	34.22	6.96	0.58	0.00	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	39.01	6.11	0.39	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	50.84	6.36	1.19	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	51.98	6.36	0.45	0.00	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	38.95	3.72	0.74	0.00	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	57.22	7.46	1.05	0.00	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	60.09	5.08	0.92	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	38.61	7.39	0.41	0.14	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	48.71	6.05	1.06	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	56.80	6.27	0.90	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	44.61	6.46	0.57	0.00	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	45.07	5.26	0.97	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	54.65	7.30	0.44	0.00	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	40.34	4.78	0.00	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	44.25	6.06	1.02	0.00	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	62.20	8.46	0.75	0.00	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	39.81	5.84	0.66	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	47.50	5.16	1.07	0.00	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	59.01	6.30	1.72	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	44.43	6.51	0.75	0.00	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	44.85	2.80	1.12	0.00	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	50.76	4.79	0.68	0.00	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	41.02	4.38	0.36	0.18	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	48.93	5.52	0.37	0.12	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	52.12	6.45	1.07	0.00	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	46.23	5.43	0.24	0.00	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	48.02	4.76	0.99	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	46.77	6.55	0.94	0.00	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	43.75	5.60	0.62	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	40.04	4.20	1.55	0.00	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	50.76	6.48	1.04	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	42.39	5.38	0.27	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	35.59	3.92	0.68	0.00	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	52.44	5.01	0.96	0.00	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	37.83	8.25	0.34	0.17	0.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	41.29	5.35	0.55	0.14	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	42.85	4.93	0.82	0.00	0.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	35.79	7.67	0.85	0.00	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	50.01	6.07	1.04	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	52.78	7.46	0.80	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	35.95	6.08	0.28	0.00	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	43.10	3.57	1.67	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	72.55	9.47	1.41	0.00	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	44.45	6.87	0.75	0.00	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	41.57	5.24	1.75	0.00	1.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	29.92	4.53	0.60	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	53.61	8.57	0.73	0.00	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	57.49	4.37	1.02	0.00	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	41.98	6.69	1.22	0.00	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	52.14	7.23	1.51	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	75.09	8.82	0.90	0.00	1.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	70.69	11.68	0.60	0.00	1.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	50.65	8.27	0.71	0.00	2.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	63.39	10.03	0.43	0.21	1.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	34.26	6.01	1.20	0.00	0.60
Schwann Cells, donor1	11498-119F4	61.31	15.42	1.50	0.00	0.38
Schwann Cells, donor2	11578-120F3	37.43	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	59.15	10.73	1.31	0.44	0.00
Sebocyte, donor1	11220-116B5	92.03	8.22	2.19	0.00	0.00
Sebocyte, donor2	11301-117B5	67.09	9.65	0.00	0.00	1.38
Sebocyte, donor3	11378-118B1	69.87	9.89	0.82	0.21	0.41
Sertoli Cells, donor1	11255-116F4	81.17	31.48	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	87.56	36.72	2.82	2.82	8.47
Skeletal Muscle Cells, donor1	11281-116I3	55.43	6.77	0.79	0.18	0.44
Skeletal Muscle Cells, donor2	11358-117H8	49.88	5.78	0.72	0.00	1.45
Skeletal Muscle Cells, donor3	11430-118G8	96.14	25.92	2.51	0.84	0.84
Skeletal Muscle Cells, donor4	11451-119A2	33.62	6.91	0.94	0.00	0.47
Skeletal Muscle Cells, donor5	11455-119A6	34.93	9.81	1.49	0.30	0.30
Skeletal Muscle Cells, donor6	11459-119B1	24.32	7.08	1.08	0.00	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	46.62	8.32	2.02	0.13	0.50
Skeletal Muscle Satellite Cells, donor2	11321-117D7	43.09	8.13	1.71	0.00	0.29
Skeletal Muscle Satellite Cells, donor3	11397-118D2	38.49	8.63	1.49	0.00	0.30
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	57.29	7.58	0.84	0.08	0.25
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	59.35	12.30	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	45.41	11.42	1.51	0.69	0.28
Skin - palm, donor1	10286-104F7	16.12	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	45.12	8.22	1.30	0.58	0.72
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	69.52	14.72	0.82	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	41.16	5.58	0.52	0.00	0.65
Small Airway Epithelial Cells, donor1	11256-116F5	46.43	8.76	0.42	0.00	1.67
Small Airway Epithelial Cells, donor2	11334-117F2	30.94	6.47	0.42	0.00	1.13
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	102.55	15.65	1.48	0.00	0.42
Small Airway Epithelial Cells, donor3	11406-118E2	49.47	3.45	0.67	0.00	0.22
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	35.49	7.41	0.62	0.93	0.93
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	220.11	100.72	6.89	0.67	4.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	127.56	21.75	2.94	4.11	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	94.58	19.01	3.31	0.44	1.55
Smooth Muscle Cells - Aortic, donor2	11360-117I1	93.33	29.53	1.58	1.18	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	118.98	31.68	6.18	2.32	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	55.04	4.00	1.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	127.62	23.82	2.79	1.60	1.06
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	71.15	19.06	2.88	0.44	0.66
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	28.81	7.17	1.02	0.13	0.38
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	30.61	4.23	1.30	0.00	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	52.57	13.29	2.66	0.59	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	57.09	11.96	1.14	0.14	0.71
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	95.33	23.10	3.25	0.16	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	38.05	6.70	0.00	0.61	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	143.71	32.08	3.54	3.54	0.76
Smooth Muscle Cells - Carotid, donor2	11362-117I3	97.93	18.36	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	75.82	8.58	4.29	0.48	0.95
Smooth Muscle Cells - Colonic, donor1	11239-116D6	38.49	7.08	1.62	0.00	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	57.04	10.55	1.29	0.43	1.08
Smooth Muscle Cells - Colonic, donor3	11396-118D1	60.04	11.02	1.47	0.21	0.52
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	127.61	26.76	3.09	0.62	1.55
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	106.71	17.25	2.16	2.16	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	76.81	17.03	1.49	0.30	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	106.86	14.34	4.44	0.00	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	55.91	8.40	1.26	0.24	0.16
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	104.87	26.57	5.03	2.42	6.84
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	136.08	31.63	3.64	0.91	1.14
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	105.06	34.42	1.81	0.60	1.81
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	61.46	10.07	1.32	0.00	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	89.62	30.09	4.13	2.66	1.73
Smooth Muscle Cells - Prostate, donor2	11335-117F3	73.00	17.28	2.38	0.63	3.01
Smooth Muscle Cells - Prostate, donor3	11465-119B7	41.09	13.19	2.28	0.25	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	90.92	20.51	3.02	0.75	0.45
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	75.02	19.50	3.75	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	55.57	40.06	3.88	1.29	7.75
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	173.01	31.62	4.19	0.47	0.93
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	155.50	29.79	10.60	7.07	2.02
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	120.03	33.85	3.13	2.51	2.51
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	73.16	24.19	5.01	0.88	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	59.48	13.58	2.92	0.50	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	47.65	8.88	1.40	0.00	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	85.49	21.16	4.61	0.58	0.58
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	68.84	17.59	3.82	1.02	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	64.50	16.17	3.38	1.88	0.19
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	75.74	18.31	2.79	0.84	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	61.67	13.32	1.76	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	94.76	22.38	2.38	0.00	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	71.20	19.82	2.69	1.96	0.73
Smooth Muscle Cells - Uterine, donor1	11258-116F7	68.71	28.94	2.65	1.10	1.10
Smooth Muscle Cells - Uterine, donor3	11466-119B8	119.66	32.77	4.10	2.63	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	42.56	7.97	0.58	0.00	1.17
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	61.09	20.89	2.38	0.26	1.32
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	36.08	17.11	2.98	0.37	1.86
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	68.99	20.12	2.16	0.36	0.72
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	76.09	18.17	1.99	1.42	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	48.45	14.57	2.36	0.39	1.58
Smooth muscle cells - airway, control, donor1	11966-126D4	46.22	12.44	1.02	0.00	1.27
Smooth muscle cells - airway, control, donor2	11967-126D5	59.10	13.58	1.60	0.40	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	38.87	11.29	0.84	0.42	2.51
Smooth muscle cells - airway, control, donor4	11969-126D7	33.00	13.75	0.92	0.00	0.46
Synoviocyte, donor1	11291-117A4	46.62	8.75	2.52	0.17	0.50
Synoviocyte, donor2	11368-117I9	32.35	6.70	0.67	0.00	0.50
Synoviocyte, donor3	11440-118H9	26.81	8.94	0.89	0.00	0.67
Trabecular Meshwork Cells, donor1	11532-120A2	166.16	23.94	2.50	2.14	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	93.16	15.86	1.98	1.98	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	102.81	21.53	2.08	0.69	0.46
Tracheal Epithelial Cells, donor1	11292-117A5	48.17	5.09	0.43	0.14	0.07
Tracheal Epithelial Cells, donor2	11369-118A1	58.76	8.12	0.77	0.00	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	46.39	9.74	0.00	0.00	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	83.66	7.14	0.74	1.97	1.35
Urethra, donor2	10319-105A4	21.58	1.80	0.00	0.00	1.80
Urothelial Cells, donor1	11520-119H8	141.07	28.69	3.98	0.27	0.27
Urothelial Cells, donor2	11600-120H7	103.75	18.43	1.20	0.40	0.80
Urothelial Cells, donor3	11681-122H7	111.85	22.00	2.29	0.23	0.69
Urothelial cells, donor0	11216-116B1	108.33	23.18	2.90	0.00	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	684.24	99.66	0.89	8.90	2.67
Whole blood (ribopure), donor090309, donation2	12180-129A2	766.27	78.63	0.00	15.73	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	568.84	56.82	0.68	8.90	2.74
Whole blood (ribopure), donor090325, donation1	12176-128I7	421.81	35.12	1.03	4.82	0.69
Whole blood (ribopure), donor090325, donation2	12177-128I8	475.28	41.25	3.49	5.81	2.32
Whole blood (ribopure), donor090612, donation1	12182-129A4	811.13	81.22	4.16	7.29	3.12
Whole blood (ribopure), donor090612, donation2	12183-129A5	542.42	64.25	2.75	7.34	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	498.44	39.25	0.91	7.30	0.91
Wilms' tumor cell line:G-401	10809-111A8	70.19	4.07	0.49	0.00	0.49
Wilms' tumor cell line:HFWT	10597-108E3	75.68	0.88	0.88	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	88.26	15.36	1.12	0.28	1.40
achilles tendon, donor2	10292-104G4	37.20	2.07	0.00	2.07	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	22.69	4.84	0.51	0.00	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	30.41	1.86	0.23	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	37.16	2.73	0.36	0.36	0.47
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	47.89	11.43	2.45	0.54	0.54
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	130.70	18.55	3.37	2.53	0.84
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	134.92	16.07	1.69	1.69	1.06
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	278.20	46.55	4.08	29.67	2.45
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	65.66	10.58	1.76	1.32	0.88
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	144.15	45.74	3.27	5.72	1.23
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	36.50	2.33	1.16	0.00	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	43.42	6.81	0.74	0.18	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	163.82	35.10	3.90	3.90	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	150.35	14.87	0.93	2.79	0.46
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	48.67	8.54	0.52	0.78	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	39.75	5.55	1.17	0.58	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	53.91	13.01	0.00	0.46	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	71.97	16.45	4.52	1.23	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	57.71	1.53	0.61	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	36.27	2.56	0.85	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	30.03	4.55	0.30	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	34.90	2.65	0.48	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	56.80	15.37	1.56	1.78	0.22
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	99.06	16.34	1.67	6.34	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	139.37	27.87	3.72	1.86	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	143.13	13.56	3.01	4.14	0.75
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	38.38	5.23	0.00	0.00	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	176.20	31.87	3.75	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	84.78	5.89	0.47	0.00	0.00
adipose tissue, adult, pool1	10010-101C1	27.77	1.55	0.93	0.00	0.62
adipose, donor1	10184-103D4	63.92	2.93	1.76	0.00	3.52
adipose, donor2	10185-103D5	53.53	4.06	1.22	0.00	2.43
adipose, donor3	10186-103D6	55.55	2.72	1.91	0.00	2.18
adipose, donor4	10187-103D7	49.40	3.47	1.73	0.00	2.60
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	104.95	5.84	1.89	0.16	0.47
adrenal gland, adult, pool1	10081-102A9	167.33	21.83	0.00	14.55	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	59.23	11.61	0.53	0.80	0.67
alveolar cell carcinoma cell line:SW 1573	10708-109H6	77.18	12.86	2.14	0.36	1.07
amniotic membrane cells, donor1	12235-129G3	38.49	6.72	0.46	0.00	0.23
amniotic membrane cells, donor2	12236-129G4	77.76	15.89	1.01	0.34	1.01
amniotic membrane cells, donor3	12237-129G5	35.35	2.36	0.29	0.00	0.00
amygdala - adult, donor10196	10167-103B5	184.98	23.72	10.67	2.37	0.00
amygdala, adult, donor10252	10151-102I7	101.99	18.05	6.49	1.82	0.41
amygdala, newborn, donor10223	10360-105E9	113.29	16.14	3.87	4.20	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	83.66	8.79	0.89	1.91	1.27
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	74.79	15.00	1.32	0.00	0.66
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	53.78	7.01	1.34	0.00	0.67
aorta, adult, pool1	10052-101G7	29.03	3.14	0.20	0.00	0.39
appendix, adult	10189-103D9	41.92	2.33	0.00	0.00	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	62.60	2.41	0.00	0.00	0.00
artery, adult	10190-103E1	6.79	1.36	0.00	0.00	2.72
astrocytoma cell line:TM-31	10425-106D2	61.42	10.14	1.88	1.30	0.58
b cell line:RPMI1788	10427-106D4	18.29	3.42	0.59	0.15	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	48.83	15.26	1.66	0.28	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	58.45	10.92	0.79	0.10	0.10
bile duct carcinoma cell line:TFK-1	10496-107C1	34.65	1.34	0.17	0.33	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	111.29	9.51	1.68	1.12	0.00
bladder, adult, pool1	10011-101C2	69.64	6.95	0.76	0.33	0.65
blood, adult, pool1	10053-101G8	183.81	31.00	0.00	2.21	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	64.23	11.99	2.57	0.86	0.00
bone marrow, adult	10192-103E3	41.84	4.05	0.67	0.67	1.35
brain, adult, donor1	10084-102B3	70.73	18.45	4.10	1.03	4.10
brain, adult, pool1	10012-101C3	111.36	16.04	7.02	1.67	1.22
brain, fetal, pool1	10085-102B4	109.53	10.69	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	81.93	6.94	0.99	0.33	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	157.28	7.49	1.00	0.50	0.12
breast, adult, donor1	10080-102A8	21.47	0.00	0.00	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	52.47	8.13	1.78	0.25	0.38
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	56.59	6.49	0.62	0.00	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	85.64	13.58	2.07	0.23	0.92
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	71.90	14.53	2.18	0.24	0.00
carcinoid cell line:NCI-H1770	10703-109H1	36.67	2.35	1.41	0.00	0.94
carcinoid cell line:NCI-H727	10735-110B6	54.03	3.50	0.55	0.00	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	40.25	1.90	0.32	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	40.46	7.72	1.86	0.00	0.00
caudate nucleus - adult, donor10196	10177-103C6	61.02	10.36	3.45	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	89.18	6.02	3.01	0.33	0.50
caudate nucleus, adult, donor10258	10379-105H1	113.09	6.11	3.82	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	76.54	5.13	0.37	3.30	0.37
cerebellum - adult, donor10196	10173-103C2	67.01	5.83	2.91	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	61.28	5.98	2.99	0.21	0.64
cerebellum, adult, pool1	10083-102B2	30.70	6.90	1.72	0.00	0.00
cerebellum, newborn, donor10223	10357-105E6	35.70	4.15	0.00	0.00	0.00
cerebral meninges, adult	10188-103D8	84.47	12.86	4.54	2.02	0.25
cerebrospinal fluid, donor2	10294-104G6	21.20	0.73	0.00	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	54.49	4.17	0.43	0.00	0.43
cervical cancer cell line:ME-180	10553-107I4	37.62	3.65	0.00	0.00	0.33
cervix, adult, pool1	10013-101C4	50.40	4.20	0.73	0.00	0.63
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	274.91	27.31	3.48	3.20	0.98
chondrosarcoma cell line:SW 1353	10700-109G7	53.56	9.14	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	103.15	6.34	0.50	0.00	3.11
choriocarcinoma cell line:SCH	10785-110H2	54.21	4.56	0.49	0.00	0.25
choriocarcinoma cell line:T3M-3	10618-108G6	114.32	13.28	1.19	0.00	1.19
chorionic membrane cells, donor1	12238-129G6	41.60	4.27	0.28	0.00	0.00
chorionic membrane cells, donor2	12239-129G7	94.76	16.70	1.99	0.20	1.79
chorionic membrane cells, donor3	12240-129G8	42.86	6.04	0.55	0.55	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	14.14	6.06	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	213.23	47.06	5.76	13.83	0.96
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	81.73	21.54	2.96	6.76	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	57.27	17.46	0.77	2.05	0.51
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	72.08	15.00	2.90	0.48	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	65.56	19.14	1.83	3.05	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	121.61	29.15	2.36	4.42	0.59
chronic myelogenous leukemia cell line:KU812	10409-106B4	109.46	12.77	3.39	5.99	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	65.83	16.46	2.06	0.00	1.60
clear cell carcinoma cell line:TEN	10636-108I6	65.24	9.37	1.56	0.52	0.35
colon carcinoma cell line:CACO-2	10513-107D9	105.43	7.69	0.92	0.00	0.37
colon carcinoma cell line:COLO-320	10420-106C6	36.49	1.14	0.76	0.00	0.00
colon, adult, donor1	10082-102B1	70.21	7.14	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	83.31	4.94	0.12	0.00	1.76
colon, fetal, donor1	10070-101I7	62.42	5.56	0.62	0.00	1.85
common myeloid progenitor CMP, donor1	12130-128D6	921.29	18.33	4.58	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	75.11	0.00	25.04	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	22.52	5.95	0.42	0.85	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	46.34	8.45	1.66	0.30	0.60
cord blood derived cell line:COBL-a untreated	10449-106F8	44.56	10.72	1.83	0.00	0.14
corpus callosum, adult, pool1	10042-101F6	65.90	6.63	1.33	0.55	0.22
cruciate ligament, donor2	10295-104G7	24.31	1.62	0.00	0.81	0.00
diaphragm, fetal, donor1	10069-101I6	23.27	1.61	1.61	0.00	0.00
diencephalon, adult	10193-103E4	39.84	4.56	2.40	0.48	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	11.25	1.61	0.23	0.00	0.23
ductal cell carcinoma cell line:KLM-1	10438-106E6	67.96	8.46	1.80	0.00	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	82.57	8.43	0.96	0.00	0.24
ductus deferens, adult	10196-103E7	91.69	10.96	1.50	1.99	1.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	60.49	4.32	0.00	1.44	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	80.19	5.89	1.47	0.00	0.00
dura mater, adult, donor1	10041-101F5	49.06	5.04	1.73	0.17	0.41
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	23.54	2.44	0.44	0.00	0.89
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	59.32	6.16	0.43	0.14	0.86
embryonic pancreas cell line:1B2C6	10604-108F1	39.46	5.55	0.62	0.00	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	34.51	6.05	2.12	0.00	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	33.04	2.78	0.31	0.00	0.31
embryonic pancreas cell line:2C6	10603-108E9	44.66	2.63	1.31	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	134.41	7.71	1.01	0.00	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	69.23	7.43	1.09	0.18	0.18
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	77.35	15.76	2.41	0.00	0.48
epidermoid carcinoma cell line:A431	10426-106D3	63.69	7.11	0.67	0.00	0.22
epidermoid carcinoma cell line:Ca Ski	10431-106D8	171.91	25.52	1.65	3.08	0.22
epididymis, adult	10197-103E8	50.44	4.81	0.84	0.00	1.47
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	64.40	7.81	1.42	0.00	0.18
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	41.29	1.97	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	104.18	17.56	2.75	3.15	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	93.60	14.86	2.76	0.98	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	112.14	19.16	1.90	2.24	0.78
esophagus, adult, pool1	10015-101C6	49.69	3.61	0.21	0.00	0.32
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	165.56	8.27	1.50	0.00	1.00
eye - muscle inferior rectus, donor1	10272-104E2	7.24	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	31.56	4.21	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	2.98	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	22.93	1.15	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	52.47	4.37	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	51.10	3.81	0.25	0.25	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	54.88	13.85	1.03	0.26	0.51
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	84.28	19.71	3.56	3.32	0.95
frontal lobe, adult, pool1	10040-101F4	147.87	18.76	7.79	1.69	0.56
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	178.05	21.62	3.00	0.60	0.90
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	104.42	16.00	1.55	0.27	0.18
gall bladder, adult	10198-103E9	79.19	8.45	0.72	1.21	2.41
gamma delta positive T cells, donor1	11937-126A2	13.96	3.76	0.54	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	14.57	0.75	1.49	0.00	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	65.27	6.55	1.06	0.42	0.63
gastric adenocarcinoma cell line:MKN45	10612-108F9	45.84	3.87	0.19	0.00	0.19
gastric cancer cell line:AZ521	10549-107H9	90.34	6.56	1.31	0.16	0.33
gastric cancer cell line:GSS	10560-108A2	49.42	1.83	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	38.38	0.91	0.46	0.00	0.91
giant cell carcinoma cell line:LU65	10487-107B1	43.83	2.64	0.34	0.00	0.23
giant cell carcinoma cell line:Lu99B	10433-106E1	100.21	17.63	1.82	4.90	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	94.78	10.72	1.50	1.50	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	247.31	41.59	6.44	5.07	0.63
glioblastoma cell line:A172, tech_rep2	10444-106F3	250.96	41.29	7.58	5.62	0.00
glioblastoma cell line:T98G	10485-107A8	68.65	15.01	1.66	0.22	0.00
glioma cell line:GI-1	10413-106B8	70.29	12.01	2.05	0.88	1.46
globus pallidus - adult, donor10196	10175-103C4	61.96	9.48	2.19	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	46.13	3.91	0.49	0.49	0.24
globus pallidus, adult, donor10258	10367-105F7	28.75	1.37	0.00	1.37	0.00
globus pallidus, newborn, donor10223	10364-105F4	50.63	2.13	1.60	1.07	1.07
granulocyte macrophage progenitor, donor1	12131-128D7	501.66	17.13	0.00	4.89	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	109.28	21.86	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	47.04	5.23	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	48.32	12.16	1.60	0.32	0.32
hIPS +CCl2, biol_rep1	14383-156B9	61.98	6.43	0.92	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	64.47	3.20	0.91	0.00	0.91
hIPS +CCl2, biol_rep3	14385-156C2	77.94	6.44	1.29	0.00	0.64
hIPS, biol_rep1	14380-156B6	56.05	2.87	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	61.04	4.12	0.00	0.00	1.37
hIPS, biol_rep3	14382-156B8	77.24	16.55	1.10	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	28.16	5.75	2.30	0.00	0.29
heart - mitral valve, adult	10205-103F7	18.83	1.49	0.30	0.30	0.30
heart - pulmonic valve, adult	10206-103F8	17.00	2.61	0.00	0.00	0.26
heart - tricuspid valve, adult	10207-103F9	49.13	7.49	0.00	0.83	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	52.44	6.94	0.61	0.00	1.22
heart, adult, diseased, donor1	10051-101G6	24.70	3.83	0.85	0.00	0.43
heart, adult, pool1	10016-101C7	24.38	0.92	0.23	0.00	0.00
heart, fetal, pool1	10046-101G1	50.72	3.70	0.21	0.10	0.21
hepatic mesenchymal tumor cell line:LI90	10778-110G4	49.06	25.30	3.39	0.00	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	64.22	1.19	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	64.53	1.44	0.22	0.00	0.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	63.96	0.73	0.49	0.00	0.24
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	68.01	0.91	0.40	0.00	0.30
hepatoma cell line:Li-7	10484-107A7	77.18	3.56	0.44	0.00	0.56
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	28.04	3.02	0.20	0.00	0.00
hippocampus - adult, donor10196	10169-103B7	139.11	24.60	5.68	1.89	1.89
hippocampus, adult, donor10252	10153-102I9	84.91	8.16	2.86	1.43	1.43
hippocampus, adult, donor10258	10374-105G5	115.52	31.87	4.98	0.50	0.00
hippocampus, newborn, donor10223	10363-105F3	86.71	7.75	4.23	0.70	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	86.67	3.05	0.00	0.00	1.83
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	79.92	2.55	0.20	0.00	1.77
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	80.48	3.55	0.51	0.00	1.52
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	95.29	6.20	1.13	0.00	5.07
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	92.18	3.36	1.29	0.00	9.55
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	101.74	3.04	0.38	0.00	7.59
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	68.61	6.71	1.17	0.00	2.63
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	64.63	5.17	1.72	0.00	7.54
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	67.15	5.00	2.09	0.00	1.25
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	53.99	3.79	0.47	0.00	2.37
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	63.00	5.95	1.61	0.16	1.93
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	47.80	3.37	0.67	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	71.04	2.66	0.47	0.00	2.03
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	70.75	3.44	0.49	0.00	2.46
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	63.71	3.49	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	96.79	4.58	0.95	0.00	7.25
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	80.24	3.49	0.44	0.00	2.62
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	95.45	4.00	0.00	0.00	4.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	51.05	3.20	0.75	0.19	2.26
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	50.93	4.55	0.45	0.00	5.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	51.06	3.13	1.88	0.31	2.82
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	56.83	6.37	1.31	0.16	3.10
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	52.84	6.10	1.45	0.29	1.45
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	66.66	7.17	1.79	0.00	3.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	90.52	4.62	0.37	0.18	1.48
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	91.29	5.71	0.29	0.00	2.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	102.08	4.08	0.00	0.00	2.86
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	101.40	8.10	1.76	0.00	6.34
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	104.21	5.38	1.90	0.32	3.17
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	115.90	5.14	1.21	0.00	3.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	74.47	7.24	2.07	0.00	2.59
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	75.71	6.64	2.66	0.00	3.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	61.05	5.90	0.51	0.00	2.05
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	71.33	10.48	2.05	0.00	2.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	77.24	12.12	1.51	0.00	3.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	67.55	8.07	2.02	0.00	1.68
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	92.01	7.73	0.97	0.24	2.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	94.03	3.12	0.89	0.00	1.78
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	102.44	4.88	1.95	0.00	2.93
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	111.24	5.81	0.31	0.00	8.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	29.28	0.00	0.00	0.00	9.76
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	114.51	5.30	0.00	0.00	6.95
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	82.09	7.11	1.64	0.00	4.93
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	86.85	7.60	1.45	0.00	3.98
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	63.35	2.85	1.07	0.00	2.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	85.92	8.35	3.58	0.00	5.97
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	82.47	7.58	2.17	0.00	4.88
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	56.57	4.85	1.35	0.00	0.81
immature langerhans cells, donor1	11904-125F5	21.31	1.70	0.24	0.00	0.00
immature langerhans cells, donor2	11905-125F6	29.31	1.58	0.79	0.00	0.00
insula, adult, pool1	10039-101F3	198.26	31.61	12.68	2.65	0.57
keratoacanthoma cell line:HKA-1	10791-110H8	58.53	5.53	0.98	0.65	0.33
kidney, adult, pool1	10017-101C8	55.27	4.11	0.50	0.10	0.10
kidney, fetal, pool1	10045-101F9	107.45	5.94	0.42	0.28	0.28
large cell lung carcinoma cell line:IA-LM	10509-107D5	96.43	7.24	1.42	1.42	0.28
large cell lung carcinoma cell line:NCI-H460	10839-111E2	34.28	2.21	0.28	0.00	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	56.70	12.11	1.28	0.37	0.18
left atrium, adult, donor1	10079-102A7	22.34	3.81	0.00	0.54	0.00
left ventricle, adult, donor1	10078-102A6	22.25	2.02	0.51	0.00	0.51
leiomyoblastoma cell line:G-402	10721-110A1	67.31	7.39	0.55	0.00	0.55
leiomyoma cell line:10964C	10569-108B2	74.72	26.58	2.87	1.08	3.59
leiomyoma cell line:15242A	10570-108B3	135.87	36.96	2.72	2.17	0.54
leiomyoma cell line:15425	10571-108B4	84.01	23.55	5.34	1.21	1.94
leiomyosarcoma cell line:Hs 5.T	10722-110A2	76.19	12.70	0.00	6.35	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	58.55	17.77	0.00	2.09	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	321.12	54.90	6.73	10.15	1.65
liposarcoma cell line:KMLS-1	10782-110G8	174.33	43.90	5.15	3.75	1.25
liposarcoma cell line:SW 872	10726-110A6	78.10	17.79	1.58	0.12	0.37
liver, adult, pool1	10018-101C9	55.26	1.62	0.49	0.00	1.94
liver, fetal, pool1	10086-102B5	15.99	1.88	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	63.00	9.04	1.02	0.58	0.58
locus coeruleus, adult, donor10252	10165-103B3	75.11	6.83	2.21	1.66	0.37
locus coeruleus, adult, donor10258	10375-105G6	99.88	18.34	3.39	1.41	1.41
locus coeruleus, newborn, donor10223	10362-105F2	66.04	10.94	0.42	0.84	2.52
lung adenocarcinoma cell line:A549	10499-107C4	48.71	4.43	0.69	0.14	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	373.66	68.94	4.14	6.20	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	46.93	4.61	0.66	0.00	0.00
lung, adult, pool1	10019-101D1	71.82	4.61	0.35	0.00	0.95
lung, fetal, donor1	10068-101I5	92.19	6.85	0.86	0.00	0.29
lung, right lower lobe, adult, donor1	10075-102A3	46.28	5.96	0.46	0.00	2.75
lymph node, adult, donor1	10077-102A5	62.01	7.10	0.00	0.00	0.47
lymphangiectasia cell line:DS-1	10727-110A7	40.55	5.04	0.66	0.00	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	7.40	0.75	0.00	0.00	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	41.63	8.49	0.85	0.00	0.85
mature adipocyte, donor1	12231-129F8	24.86	0.44	0.00	0.00	0.00
mature adipocyte, donor2	12232-129F9	19.30	1.04	0.00	0.00	0.21
mature adipocyte, donor3	12233-129G1	25.84	0.71	0.47	0.00	0.47
mature adipocyte, donor4	12234-129G2	12.37	0.26	0.00	0.00	0.53
maxillary sinus tumor cell line:HSQ-89	10414-106B9	51.94	2.86	0.24	0.00	0.71
medial frontal gyrus - adult, donor10196	10170-103B8	139.88	16.92	2.26	1.13	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	84.23	12.14	4.41	1.29	0.37
medial frontal gyrus, adult, donor10258	10368-105F8	82.92	26.37	4.45	1.27	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	66.11	8.10	2.13	1.71	0.85
medial temporal gyrus - adult, donor10196	10183-103D3	141.58	26.49	6.41	2.70	0.34
medial temporal gyrus, adult, donor10252	10156-103A3	73.64	13.37	2.97	1.27	0.85
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	104.02	30.82	1.93	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	28.71	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	129.57	14.72	6.46	2.15	0.72
medulla oblongata - adult, donor10196	10174-103C3	45.43	6.49	0.00	0.65	0.65
medulla oblongata, adult, donor10252	10155-103A2	63.01	5.88	1.55	0.77	0.31
medulla oblongata, adult, pool1	10038-101F2	87.67	9.63	2.94	0.82	0.33
medulla oblongata, newborn, donor10223	10361-105F1	83.67	9.72	3.12	0.35	0.00
medulloblastoma cell line:D283 Med	10838-111E1	49.82	2.44	0.00	0.00	0.22
medulloblastoma cell line:ONS-76	10759-110E3	97.08	11.37	1.96	0.37	0.12
melanoma cell line:COLO 679	10514-107E1	27.60	9.06	1.44	0.00	0.43
melanoma cell line:G-361	10465-106H6	18.73	3.53	0.54	0.00	0.81
meningioma cell line:HKBMM	10691-109F7	73.45	22.61	2.53	3.26	0.90
merkel cell carcinoma cell line:MKL-1	10843-111E6	46.70	1.76	0.00	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	35.77	0.52	0.00	0.00	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	52.63	15.19	1.99	0.77	0.92
mesenchymal precursor cell - adipose, donor2	11748-123G2	36.36	9.27	1.27	0.18	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	54.66	19.05	2.48	0.41	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	27.11	9.69	0.84	0.00	0.28
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	36.59	9.82	1.35	0.39	0.39
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	68.02	20.82	3.47	0.00	1.39
mesenchymal precursor cell - cardiac, donor1	11752-123G6	62.82	14.76	1.72	0.17	0.86
mesenchymal precursor cell - cardiac, donor2	11753-123G7	56.24	14.61	1.50	0.23	1.15
mesenchymal precursor cell - cardiac, donor3	11754-123G8	50.93	12.60	1.19	0.13	0.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	56.85	16.34	1.76	0.27	0.68
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	74.83	23.05	2.99	0.14	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	56.32	12.84	1.32	0.00	0.99
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	76.66	21.17	3.60	0.42	1.11
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	110.31	31.42	6.28	0.35	1.05
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	70.44	34.91	4.49	0.00	1.63
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	78.72	18.69	2.16	1.08	1.80
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	65.59	23.69	2.79	0.00	0.21
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	131.10	32.37	5.47	1.60	1.60
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	44.89	14.68	1.68	1.26	0.84
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	52.60	18.83	2.69	0.30	1.34
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	76.06	22.15	1.84	0.53	0.53
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	73.26	19.51	6.26	0.37	0.74
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	78.41	22.61	3.43	0.29	2.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	64.42	13.89	2.53	0.00	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	48.41	14.16	1.37	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	46.30	14.32	0.26	0.77	1.28
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	56.28	11.26	0.52	0.26	1.05
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	58.54	14.48	2.46	0.31	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	53.66	15.30	0.94	0.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	56.86	11.85	1.69	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	55.80	13.36	1.96	0.79	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	56.07	8.80	1.85	0.00	0.93
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	62.87	17.02	2.02	0.29	1.15
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	50.87	9.59	1.34	0.89	0.45
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	55.04	13.94	0.72	0.48	0.72
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	52.07	11.00	2.20	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	57.40	11.75	0.00	0.00	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	48.31	7.37	1.23	0.82	1.23
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	47.25	18.04	2.15	1.29	0.86
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	76.56	8.20	5.47	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	36.15	10.33	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	47.42	7.79	1.30	0.00	1.95
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	61.11	16.00	4.36	2.91	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	63.97	14.39	3.20	1.07	1.07
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	47.43	14.72	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	47.81	12.83	1.17	0.39	0.78
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	39.88	14.69	0.00	0.00	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	46.69	8.94	0.99	0.00	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	47.67	14.30	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	46.25	6.52	0.59	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	57.27	13.40	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	54.10	27.05	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	63.34	8.23	1.27	0.00	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	36.21	7.59	1.72	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	38.69	8.60	0.00	0.00	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	39.92	7.98	3.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	20.66	3.44	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	34.63	7.33	1.22	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	29.39	5.56	0.79	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	15.92	3.54	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	17.14	4.05	0.62	0.00	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	21.39	5.35	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	27.20	7.10	0.00	0.00	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	28.25	2.57	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	28.91	5.51	0.69	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	34.14	0.99	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	35.89	2.24	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	27.99	1.27	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	49.97	2.42	0.40	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	39.25	2.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	60.82	1.27	2.53	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	42.48	1.82	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	31.63	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	48.60	3.29	0.00	0.00	3.29
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	19.45	3.17	0.79	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	17.20	1.62	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	22.41	5.09	1.02	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	40.23	2.32	0.77	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	120.72	17.01	3.31	0.00	0.71
mesothelioma cell line:ACC-MESO-4	10494-107B8	163.10	22.24	3.01	3.71	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	179.49	51.28	0.00	0.00	12.82
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	261.50	45.52	3.70	6.06	1.54
mesothelioma cell line:Mero-25	10850-111F4	45.39	4.09	0.91	0.23	0.45
mesothelioma cell line:Mero-41	10851-111F5	107.32	30.31	2.44	0.73	0.73
mesothelioma cell line:Mero-48a	10852-111F6	138.62	38.09	4.65	6.64	0.66
mesothelioma cell line:Mero-82	10853-111F7	93.03	10.51	0.00	0.26	0.79
mesothelioma cell line:Mero-83	10854-111F8	172.77	42.38	3.57	4.60	3.92
mesothelioma cell line:Mero-84	10855-111F9	65.22	15.67	2.02	0.25	0.25
mesothelioma cell line:Mero-95	10856-111G1	150.93	33.75	3.31	5.59	2.48
mesothelioma cell line:NCI-H2052	10847-111F1	147.43	36.11	4.47	3.15	0.83
mesothelioma cell line:NCI-H226	10846-111E9	124.34	27.69	2.90	1.27	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	170.99	39.29	3.07	2.90	0.85
mesothelioma cell line:NCI-H28	10845-111E8	60.56	12.98	1.27	0.00	0.00
mesothelioma cell line:No36	10857-111G2	57.74	5.87	0.98	0.00	0.33
mesothelioma cell line:ONE58	10858-111G3	85.35	25.74	1.90	1.08	0.27
migratory langerhans cells, donor1	11901-125F2	37.81	9.21	0.96	0.00	0.19
migratory langerhans cells, donor2	11902-125F3	31.63	7.33	0.85	0.24	0.37
migratory langerhans cells, donor3	11903-125F4	21.00	4.85	1.08	0.00	0.36
mixed mullerian tumor cell line:HTMMT	10689-109F5	31.67	5.88	0.33	0.00	0.65
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	90.28	13.35	1.06	0.64	2.33
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	36.63	2.99	0.23	0.46	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	18.84	4.95	0.57	0.00	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	84.27	8.50	1.29	2.03	0.00
myeloma cell line:PCM6	10474-106I6	14.63	2.77	0.40	0.00	0.40
myxofibrosarcoma cell line:MFH-ino	10600-108E6	100.95	33.99	4.57	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	21.18	5.10	0.39	0.00	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	37.77	0.89	0.22	0.00	0.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	34.56	1.76	0.66	0.00	0.00
nasal epithelial cells, donor2	12227-129F4	36.98	3.86	0.00	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	19.56	0.92	0.46	0.00	0.00
neuroblastoma cell line:NB-1	10539-107G8	35.92	4.49	1.50	0.37	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	39.86	6.12	1.48	0.00	0.21
neuroblastoma cell line:NH-12	10555-107I6	34.85	2.61	0.19	0.00	0.19
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	40.33	3.32	0.95	0.24	0.24
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	73.49	6.49	0.48	0.00	0.48
neuroectodermal tumor cell line:TASK1	10774-110F9	26.16	1.21	0.40	0.00	0.20
neuroepithelioma cell line:SK-N-MC	10728-110A8	55.31	3.81	0.00	0.00	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	61.22	12.51	2.66	0.27	0.53
neutrophil PMN, donor1	12133-128D9	550.37	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	39.84	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	75.77	9.47	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	36.53	3.04	0.00	0.17	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	41.63	0.80	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	53.22	14.11	2.56	0.32	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	55.71	13.93	2.63	0.00	0.79
nucleus accumbens, adult, pool1	10037-101F1	148.76	16.97	7.31	1.41	0.47
occipital cortex - adult, donor10196	10172-103C1	61.81	20.60	8.24	2.06	0.00
occipital cortex, adult, donor10252	10163-103B1	59.04	8.86	2.68	0.00	0.27
occipital cortex, newborn, donor10223	10355-105E4	123.38	14.19	3.64	3.64	0.36
occipital lobe, adult, donor1	10076-102A4	86.85	19.94	6.04	1.05	2.10
occipital lobe, fetal, donor1	10073-102A1	79.38	6.44	2.15	0.00	0.86
occipital pole, adult, pool1	10036-101E9	110.46	19.16	5.83	1.58	0.16
olfactory region, adult	10195-103E6	91.90	17.58	4.01	0.57	0.76
optic nerve, donor1	10277-104E7	14.01	4.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	74.61	7.18	0.80	0.00	0.80
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	75.56	5.36	0.14	0.00	0.41
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	38.27	4.06	0.51	0.00	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	27.38	6.01	0.81	0.12	0.92
osteoclastoma cell line:Hs 706.T	10704-109H2	36.75	8.53	0.88	0.00	0.59
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	65.40	10.28	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	79.52	8.27	0.42	0.42	0.42
ovary, adult, pool1	10020-101D2	70.93	3.14	0.70	0.09	0.79
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	57.75	9.53	0.37	0.00	0.37
pancreas, adult, donor1	10049-101G4	52.68	2.82	0.00	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	79.11	6.99	1.40	0.00	1.40
papillary adenocarcinoma cell line:8505C	10437-106E5	84.15	12.61	1.70	0.17	0.34
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	122.53	20.37	1.82	1.49	0.17
paracentral gyrus, adult, pool1	10035-101E8	123.37	20.50	7.60	1.56	0.55
parietal cortex, adult, donor10258	10373-105G4	61.66	11.74	2.94	0.73	0.00
parietal lobe - adult, donor10196	10171-103B9	71.48	14.11	2.82	0.94	0.94
parietal lobe, adult, donor10252	10157-103A4	76.10	10.83	4.28	3.14	0.00
parietal lobe, adult, pool1	10034-101E7	122.49	21.24	7.05	1.41	0.44
parietal lobe, fetal, donor1	10072-101I9	69.83	7.76	1.94	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	100.57	14.58	1.87	1.50	1.50
parotid gland, adult	10199-103F1	25.28	3.08	0.62	0.00	0.62
penis, adult	10200-103F2	27.39	2.15	0.00	0.00	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	34.77	1.67	1.12	0.00	0.19
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	38.90	6.12	0.58	0.29	0.15
pineal gland - adult, donor10196	10179-103C8	110.94	46.44	5.81	21.93	1.94
pineal gland, adult, donor10252	10160-103A7	120.22	34.35	4.15	17.17	0.00
pineal gland, adult, donor10258	10377-105G8	142.97	42.64	5.02	15.05	0.63
pituitary gland - adult, donor10196	10180-103C9	69.81	15.18	0.00	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	58.89	9.90	0.52	0.00	1.04
pituitary gland, adult, donor10258	10378-105G9	78.31	13.62	0.00	0.00	1.70
placenta, adult, pool1	10021-101D3	66.76	5.27	0.75	0.00	0.32
plasma cell leukemia cell line:ARH-77	10840-111E3	20.39	3.84	0.26	0.00	0.13
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	45.45	7.94	0.47	0.00	0.16
pons, adult, pool1	10033-101E6	111.97	18.42	4.99	1.81	0.77
postcentral gyrus, adult, pool1	10032-101E5	122.48	16.48	8.37	1.48	0.35
promyelocytes/myelocytes PMC, donor1	12132-128D8	330.44	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	16.52	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	23.47	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	83.46	8.74	1.31	0.00	0.29
prostate cancer cell line:PC-3	10439-106E7	125.60	17.24	1.63	0.18	0.18
prostate, adult, pool1	10022-101D4	63.85	5.44	0.63	0.36	0.91
putamen, adult, donor10196	10176-103C5	163.36	8.97	4.72	1.18	0.94
putamen, adult, donor10252	10152-102I8	54.90	3.92	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	69.94	4.37	1.09	0.00	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	65.24	5.80	2.42	0.00	0.48
putamen, newborn, donor10223	10365-105F5	47.23	10.50	0.00	0.75	0.00
rectal cancer cell line:TT1TKB	10469-106I1	50.62	2.62	0.00	0.29	0.00
rectum, fetal, donor1	10067-101I4	86.24	4.17	4.17	0.00	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	78.44	16.96	4.03	0.21	0.85
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	65.45	4.56	0.41	0.00	0.00
retina, adult, pool1	10030-101E3	59.44	5.07	1.29	0.00	0.40
retinoblastoma cell line:Y79	10475-106I7	55.34	4.42	0.26	0.00	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	36.76	1.97	0.12	0.00	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	62.15	3.09	0.56	0.00	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	62.90	13.64	1.52	0.00	0.00
salivary acinar cells, donor1	11771-123I7	45.97	6.47	0.65	0.00	0.32
salivary acinar cells, donor2	11772-123I8	33.04	2.48	0.55	0.00	0.96
salivary acinar cells, donor3	11773-123I9	39.06	3.97	0.00	0.00	0.00
salivary gland, adult, pool1	10093-102C3	44.61	3.43	0.00	0.00	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	28.92	4.13	0.93	0.59	0.17
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	25.86	4.35	1.53	0.24	0.24
seminal vesicle, adult	10201-103F3	81.48	10.58	1.59	0.00	1.59
serous adenocarcinoma cell line:JHOS-2	10639-108I9	59.76	8.50	0.49	0.00	0.97
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	72.22	4.28	0.00	0.00	0.75
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	103.36	7.02	1.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	81.53	1.75	0.00	0.13	0.27
signet ring carcinoma cell line:Kato III	10436-106E4	26.75	1.77	0.22	0.00	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	53.03	6.97	0.90	0.26	0.39
skeletal muscle - soleus muscle, donor1	10282-104F3	2.84	0.00	0.00	0.00	0.71
skeletal muscle, adult, pool1	10023-101D5	15.47	0.72	0.00	0.00	0.00
skeletal muscle, fetal, donor1	10066-101I3	37.19	4.02	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	40.71	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	47.97	4.42	0.00	0.63	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	83.05	9.01	1.67	0.00	0.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	46.65	3.78	0.32	0.00	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	106.59	16.58	3.08	0.00	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	19.78	2.64	0.33	0.00	0.16
small cell lung carcinoma cell line:NCI-H82	10842-111E5	43.43	0.80	0.00	0.00	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	43.58	5.23	1.53	0.00	0.44
small intestine, adult, pool1	10024-101D6	153.60	8.60	0.84	0.36	1.67
small intestine, fetal, donor1	10064-101I1	71.25	7.13	0.98	0.00	0.49
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	44.11	3.08	1.54	0.00	1.54
smooth muscle, adult, pool1	10048-101G3	33.34	2.84	0.78	0.00	0.26
somatostatinoma cell line:QGP-1	10781-110G7	50.92	4.82	0.80	0.27	0.00
spinal cord - adult, donor10196	10181-103D1	55.98	6.19	1.38	0.92	0.46
spinal cord, adult, donor10252	10159-103A6	50.86	5.13	1.18	0.00	0.00
spinal cord, adult, donor10258	10369-105F9	37.36	6.23	0.69	0.69	0.00
spinal cord, fetal, donor1	10056-101H2	73.79	9.76	2.44	0.00	0.00
spinal cord, newborn, donor10223	10359-105E8	53.27	6.43	0.00	0.00	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	52.27	14.49	2.69	0.00	0.15
spleen, adult, pool1	10025-101D7	62.01	4.19	0.88	0.33	0.44
spleen, fetal, pool1	10044-101F8	74.85	5.16	0.48	0.56	0.40
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	17.18	1.66	0.10	0.00	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	32.28	1.52	0.00	0.00	0.38
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	97.50	13.63	1.40	0.00	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	39.09	8.99	2.35	0.39	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	41.53	2.25	0.56	0.00	0.11
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	61.85	7.20	0.85	0.00	0.85
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	44.42	9.73	0.85	0.00	0.00
stomach, fetal, donor1	10062-101H8	41.65	6.41	1.07	0.00	0.00
submaxillary gland, adult	10202-103F4	29.62	0.57	0.57	0.00	0.57
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	47.15	2.28	0.62	0.42	0.83
substantia nigra, adult, donor10258	10371-105G2	63.62	13.45	1.55	0.52	0.00
substantia nigra, newborn, donor10223	10358-105E7	40.27	8.48	0.00	0.00	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	110.51	14.21	3.44	0.00	0.00
temporal lobe, adult, pool1	10031-101E4	178.19	26.28	10.17	2.12	0.93
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	76.21	10.68	4.27	0.00	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	94.06	11.87	2.64	0.00	0.88
tenocyte, donor1	11763-123H8	59.00	15.71	4.89	0.00	0.35
tenocyte, donor2	11765-123I1	44.64	8.39	0.76	0.00	0.38
tenocyte, donor3	11768-123I4	37.07	14.46	1.11	0.37	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	84.30	5.10	0.34	0.00	0.34
teratocarcinoma cell line:NCR-G1	10798-110I6	102.82	7.24	1.39	0.31	0.46
teratocarcinoma cell line:PA-1	10807-111A6	72.06	5.89	0.31	0.00	0.46
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	53.57	3.81	0.51	0.51	0.89
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	47.65	2.27	0.76	0.76	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	14.83	1.09	0.00	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	31.59	0.65	0.00	0.00	0.65
testis, adult, pool1	10026-101D8	245.13	14.28	3.44	0.21	3.76
testis, adult, pool2	10096-102C6	283.73	28.42	2.26	0.00	0.90
thalamus - adult, donor10196	10168-103B6	62.93	5.52	0.00	0.00	0.00
thalamus, adult, donor10252	10154-103A1	48.45	4.22	0.94	0.00	0.63
thalamus, adult, donor10258, tech_rep1	10370-105G1	43.11	15.40	0.00	0.00	3.08
thalamus, adult, donor10258, tech_rep2	10370-105G1	41.67	6.42	1.15	0.16	0.16
thalamus, newborn, donor10223	10366-105F6	101.26	20.14	4.60	1.15	1.73
throat, adult	10209-103G2	26.71	2.25	0.25	0.00	0.00
throat, fetal, donor1	10061-101H7	36.56	2.74	1.22	0.00	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	62.20	8.35	1.59	0.00	0.20
thymus, adult, pool1	10027-101D9	38.08	2.39	0.60	0.10	0.89
thymus, fetal, pool1	10043-101F7	58.71	3.22	0.94	1.25	0.83
thyroid carcinoma cell line:KHM-5M	10776-110G2	99.85	14.63	1.33	0.53	0.93
thyroid carcinoma cell line:TCO-1	10783-110G9	68.87	10.06	1.40	0.56	0.14
thyroid, adult, pool1	10028-101E1	79.97	4.95	0.56	0.09	0.56
thyroid, fetal, donor1	10060-101H6	42.98	3.95	0.26	0.00	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	27.72	0.00	3.08	0.00	3.08
tongue, adult	10203-103F5	28.14	1.86	0.23	0.00	0.47
tongue, fetal, donor1	10059-101H5	26.40	2.76	0.00	0.00	0.00
tonsil, adult, pool1	10047-101G2	44.78	3.61	0.70	0.00	0.10
trachea, adult, pool1	10029-101E2	73.62	6.38	0.74	0.25	0.33
trachea, fetal, donor1	10058-101H4	39.62	4.62	1.15	0.00	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	70.86	13.11	1.42	0.71	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	82.57	11.65	1.82	0.71	0.10
transitional-cell carcinoma cell line:JMSU1	10492-107B6	85.55	9.40	1.10	0.63	0.78
tridermal teratoma cell line:HGRT	10694-109G1	60.88	5.71	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	38.52	4.23	0.34	0.17	0.25
umbilical cord, fetal, donor1	10057-101H3	27.12	2.09	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	43.85	5.46	0.68	0.00	0.17
uterus, fetal, donor1	10055-101H1	49.15	8.19	0.51	0.00	0.00
vagina, adult	10204-103F6	84.01	7.11	0.65	3.23	1.94
vein, adult	10191-103E2	28.50	1.32	0.22	0.00	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	16.02	2.14	0.27	0.00	0.00